???global.info.a_carregar???
Identification

Personal identification

Full name
Maria de Fátima Monginho Baltazar

Author identifiers

Ciência ID
FE1F-3F98-8FC3

Languages

Language Speaking Reading Writing Listening Peer-review
Spanish; Castilian Beginner (A1) Upper intermediate (B2) Beginner (A1) Upper intermediate (B2) Upper intermediate (B2)
Education
Degree Classification
1998/12/01 - 2003/09/30
Concluded
 Characterization and purification of the lactate transporter of C. utilis (Pós-doutoramento)
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
1994/10/01 - 1998/06/01
Concluded
 Department of Biological Sciences (Doctor of Philosophy)
University of Hull, United Kingdom
"Studies of the Enzymology of Fatty Acid Oxidation and of Methyl Ketone Production in Aspergillus Niger" (THESIS/DISSERTATION)
1986/10/01 - 1992/05/01
Concluded
 Ciências Farmacêuticas (Licenciatura)
Major in Farmácia de Oficina e Hospitalar
Universidade de Coimbra Faculdade de Farmácia, Portugal
 16 valores
Affiliation

Science

Category
Host institution 		Employer
2004 - Current Principal Investigator (Research) Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Teaching in Higher Education

Category
Host institution 		Employer
2014/05/01 - Current Associate Professor (University Teacher) Universidade do Minho Escola de Medicina, Portugal
2005/05/01 - 2010/05/01 Assistant Professor (University Teacher) Universidade do Minho Escola de Medicina, Portugal
2003/09/01 - 2005/05/01 Invited Assistant Professor (University Teacher) Universidade do Minho Escola de Medicina, Portugal
Projects

Grant

Designation Funders
2020/03/30 - 2023/05/31 Syncrother - New chromen derivatives for cancer therapy
046826
Researcher
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
 European Regional Development Fund
Ongoing
2019/04/10 - 2023/04/09 Sourdough biotechnology network towards novel, healthier and sustainable food and bioprocesses
CA18101
Researcher
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Universidade do Porto Instituto de Ciências e Tecnologias Agrárias e Agro-Alimentares, Portugal
European Cooperation in Science and Technology
Ongoing
2021/04 - 2023/03 Janus Approach to Cancer Theranostics (JUSThera)
NORTE-01-0145-FEDER-000055
Researcher
Laboratório Associado ICVS 3B's, Portugal
 European Regional Development Fund
Ongoing
2020/04 - 2023/03 SENTINEL – Novel injectable biosensor for continuous remote monitoring of cancer patients at high-risk of relapse
NORTE-01-0247-FEDER-045914
NORTE-01-0247-FEDER-045914
PI from ICVS
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

International Iberian Nanotechnology Laboratory, Portugal

Stemmatters Biotecnologia e Medicina Regenerativa SA, Portugal

Centro Clínico Académico, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2018/01/01 - 2021/12/31 Local specific treatment of triple-negative-breast-cancer through externally triggered target-less drug carriers-TMagTargetON
PTDC/BTM-SAL/31142/2017
PI from ICVS
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

International Iberian Nanotechnology Laboratory, Portugal

Universidade do Minho, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2020/01/01 - 2021/06/30 Study the anticancer effect of 3-bromopyruvate (3-BrPa) in animal model systems of Leukemia
[NewGLP] NGLP_2019
Principal Investigator
NewGLab Pharma, United States
 NewGLab Pharma
Concluded
2018/07/01 - 2021/06/30 Microbiota in cancer immunosurveillance: new avenues for immunotherapy-MiONCOTher
PTDC/MED-ONC/28658/2017
Researcher
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2018/11/01 - 2020/07/31 TAMs-targeted and externally controlled nanotheranostics of triple negative breast cancer¿ NANOTHER
UTAP-EXPL/NTec/0038/2017
PI from ICVS
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

International Iberian Nanotechnology Laboratory, Portugal

University of Texas at Austin, United States
Fundação para a Ciência e a Tecnologia
Ongoing
2016/01/01 - 2020/03/31 New avenues for the development of personalized medical interventions for neurological, oncologic and surgical disorders
NORTE 01-0145-FEDER-000013
Researcher
Laboratório Associado ICVS 3B's, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
European Regional Development Fund
Ongoing
2013 - 2016 Estudo do efeito antineoplásico de extratos e derivados de Euphorbia tirucalli em tumores cerebrais e células tronco tumorais cerebrais
MCTI/CNPq Nº73/2013
Researcher
Hospital de Amor, Brazil
 Conselho Nacional de Desenvolvimento Científico e Tecnológico
Concluded
2013/06 - 2015/09 Concise and Highly Stereoselective Strategy in the Synthesis of Aza-sugars. Theoretical Studies and Biological Evaluation of Products.
grant.Provided by PTCRIS: 126927
PTDC/QEQ-MED/1671/2012
Researcher
Universidade do Minho Centro de Química, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Universidade do Minho, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2009/03/01 - 2015/02/28 HPV e microambiente tumoral
2008/03232-1
Researcher
Universidade de São Paulo, Brazil
 Fundação de Amparo à Pesquisa do Estado de São Paulo
Concluded
2011/04 - 2014/06 Role of monocarboxylate transporters (MCTs) in the metabolism of prostate cancer
grant.Provided by PTCRIS: 113415
PTDC/SAU-MET/113415/2009
Principal investigator
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2011/02 - 2014/04 Potential predictive biomarkers of anti-RTKs therapy response in gliomas: An “in vitro” and “in vivo” Study
grant.Provided by PTCRIS: 114549
PTDC/SAU-TOX/114549/2009
Researcher
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Universidade do Minho, Portugal

Fundação da Faculdade de Ciências da Universidade de Lisboa, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2013 - 2014 PROJECTO ESTRATÉGICO - LA 26 - 2013-2014
PEst-C/SAU/LA0026/2013
Researcher
Laboratório Associado ICVS 3B's, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2010/04 - 2013/06 Monocarboxylate transporters as potential therapeutic targets in cancer: inhibition studies in solid tumor models
grant.Provided by PTCRIS: 104347
PTDC/SAU-FCF/104347/2008
Principal investigator
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Universidade do Minho, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
1998/12/01 - 2003/09/30 Characterization and purification of the lactate transporter of Candida utilis
PRAXIS XXI – BPD18842¿/98
Post-doc Fellow
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
1998/12 - 2003/09 Characterization and purification of the lactate transporter of Candida utilis
PRAXIS XXI BPD18842¿/98
 Fundação para a Ciência e a Tecnologia

Contract

Designation Funders
2021/01/01 - 2025/12/31 ICVS/3B¿s - Laboratório Associado, Instituto de Ciências da Vida e da Saúde / Grupo de Investigação em Biomateriais, Biodegradaveis e Biomiméticos
LA/P/0050/2020
10.54499/LA/P/0050/2020
UID/Multi/50026/2019
Universidade do Minho, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2018/07/02 - 2021/12/31 Tratamento local específico de cancro da mama triplo negativo por meio de fármacos pouco especificos externamente ativados
PTDC/BTM-SAL/31142/2017
International Iberian Nanotechnology Laboratory, Portugal

Universidade do Minho, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2018/07/01 - 2021/12/31 Microbiota na imunidade contra cancro: novas avenidas para imunoterapia
PTDC/MED-ONC/28658/2017
Universidade do Minho, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2011/01/01 - 2012/12/31 Strategic Project - LA 26 - 2011-2012
PEst-C/SAU/LA0026/2011
Universidade do Minho, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
Outputs

Publications

Book
  1. Tomas Koltai; Baltazar, Fátima; Khalid O. Alfarouk; Afonso, Julieta; Larry Fliegel; Stephan J. Reshkin; Rosa Angela Cardone. Corresponding author: Tomas Koltai. pH Deregulation as the Eleventh Hallmark of Cancer. Elsevier Inc.. 2023.
    Published • Editor
  2. Baltazar, F. Prostate Cancer Metabolism, From Biochemistry to Therapeutics. Elsevier. 2021.
    Published
  3. Almeida Aguiar, Cristina; Silva Carvalho, Ricardo; Baltazar, Fátima. Antitumor properties of honeybee plant-derived products: honey, propolis and pollen. Portugal: Bentham Science Publishers. 2016.
Book chapter
  1. Baltazar, Fátima; Valente, Diana; Afonso, Julieta; Queirós, Odília; Granja, Sara. "New horizons on pH regulators as cancer biomarkers and targets for pharmacological intervention". In An Innovative Approach to Understanding and Treating Cancer: Targeting pH, 417-450. Elsevier, 2020.
    10.1016/b978-0-12-819059-3.00017-4
  2. Pereira-Nunes, A.; Afonso, J.; Granja, S.; Baltazar, F.. "Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect". 51-74. 2020.
    10.1007/978-3-030-34025-4_3
  3. Pires Celeiro, Sónia; Baltazar, Fátima; Viana-Pereira, Marta. "3D culture systems as models for solid tumors and cancer metabolism". In Biomaterials for 3D Tumor Modeling, 131-155. Elsevier, 2020.
    10.1016/b978-0-12-818128-7.00006-x
  4. Pontes, Olivia; Raquel-Cunha, Ana; Oliveira-Pinto, Sofia; Baltazar, Fatima; Martinho, Olga; Costa, Marta. "Angiogenesis and Chromene-based Antiangiogenic Therapeutic Agents". In Anti-Angiogenesis Drug Discovery and Development: Volume 5, 151-188. BENTHAM SCIENCE PUBLISHERS, 2020.
    10.2174/9789811432873120050007
  5. Baltazar, F. "Targeting Metabolic Reprogramming as an Anti- Cancer Strategy: Aiming at Monocarboxylate Transporters". In Frontiers in Anti-Cancer Drug Discovery, 3-65. BENTHAM SCIENCE PUBLISHERS, 2015.
    10.2174/9781681081496115060003
  6. Gonçalves, Vera Miranda; Baltazar, Fátima; Reis, Rui Manuel. "Brain Tumor Metabolism — Unraveling Its Role in Finding New Therapeutic Targets". In Molecular Considerations and Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor. InTech, 2015.
    10.5772/59606
  7. Granja, Sara; Marchiq, Ibtissam; Baltazar, Fátima; Pouysségur, Jacques. "Gene Disruption Using Zinc Finger Nuclease Technology". In Methods in Molecular Biology, 253-260. Springer New York, 2014.
    10.1007/978-1-4939-0856-1_17
Conference paper
  1. Correia, P. R.; Almeida Aguiar, Cristina; Fonseca, António Maurício da Costa; Baltazar, Fátima; Neves, Isabel C.. "Dual nanomaterial systems aiming antimicrobial activity and cancer treatment". 2018.
  2. Amorim, Ricardo; Vilaça, Natália; Fonseca, António Manuel; Neves, Isabel C.; Preto, Ana; Baltazar, Fátima. "Enhancing 5-FU activity in colorectal carcinoma-derived cell lines: combination with monocarboxylate transporter inhibitors and encapsulation into zeolites". 2012.
  3. Vilaça, Natália; Amorim, Ricardo; Baltazar, Fátima; Fonseca, António Manuel; Neves, Isabel C.. "Zeolites: promising candidates for drug delivery systems (DDSs)". 2012.
  4. Pedro, Dalila Fernanda Neto; Ramos, Alice A.; Lima, Cristóvão F.; Baltazar, Fátima; Wilson, Cristina Pereira. "Diet and colon cancer - modulation of signaling pathways and DNA damage prevention". 2011.
  5. Amorim, Ricardo; Pereira, Helena Paula Fernandes; Preto, Ana; Baltazar, Fátima; Martins, Sandra; Pinheiro, Céline; Reis, R. L.; Longatto Filho, Adhemar. "Monocarboxylate transporters - new molecular targets for colorectal carcinoma?". 2011.
  6. Amorim, Ricardo; Martins, Sandra; Pereira, Helena Paula Fernandes; Pinheiro, Céline; Reis, R. L.; Longatto Filho, Adhemar; Preto, Ana; Baltazar, Fátima. "Monocarboxylate transporters as new attractive targets for colorectal carcinoma therapy". 2011.
  7. Valença, Isabel; Cunha, Ana; Baltazar, Fátima; Aguiar, Cristina. "Search for portuguese propolis antimicrobial activity in a wide range of microorganisms". 2011.
  8. Pedro, Dalila Fernanda Neto; Ramos, Alice A.; Lima, Cristóvão F.; Baltazar, Fátima; Wilson, Cristina Pereira. "DNA damage prevention and signaling pathway regulation by sage in a colon cancer model". 2011.
  9. Silva, Isabel Soares; Schuller, Dorit Elisabeth; Andrade, Raquel P.; Baltazar, Fátima; Cássio, Fernanda; Casal, Margarida. "Functional expression of the lactate permease Jen1p of Saccharomyces cerevisiae in Pichia pastoris". 2003.
Conference poster
  1. Olívia Pontes; Marta Costa; Sofia Oliveira-Pinto; Fernanda Proença; Baltazar, F. "Chromene derivatives: a new strategy to overcome renal cancer resistance.". Paper presented in 6th Annual ISCaM Meeting 2019, 2019.
  2. Andreia Nunes; Helena Ferreira; Nuno Neves; Baltazar, F; Sara Granja. "Disruption of cancer cell metabolism using targeted drug delivery systems.". Paper presented in 6th Annual ISCaM Meeting 2019, 2019.
  3. Sara Gomes; Sara Granja; Elisabete Silva; Baltazar, F; Ana Preto. "Unveiling the role of diet microbiome-derived short chain fatty acids in colorectal cancer metabolism.". Paper presented in 6th Annual ISCaM Meeting 2019, 2019.
  4. Andreia Barbosa; Julieta Afonso; Paula Roberta Aguiar Pastrez; Baltazar, F; Adhemar Longatto-Filho. "Characterization of glycolytic metabolism of esophageal carcinomas and evaluation of its potential as therapeutic target.". Paper presented in 6th Annual ISCaM Meeting 2019, 2019.
  5. Beatriz Gomes-Rosa; Catarina Sobral-Silva; Baltazar, F. "Prognostic value of Monocarboxylate transporter 1 overexpression in different cancer types: a systematic review.". Paper presented in 6th Annual ISCaM Meeting 2019, 2019.
  6. Ana Margarida Barbosa; Catarina M. Ferreira; Carolina Ferreira; Ine^s Mesquita; Alexandra Fraga; Adhemar Longatto-Filho; Nuno Oso´rio; et al. "Commensal gut bacteria modulate immune surveillance and promote extra-intestinal tumor overgrowth.". Paper presented in 6th Annual ISCaM Meeting 2019, 2019.
  7. Beatriz Carvalho-Antunes; Alberta Sobral-Baptista; Baltazar, F. "Evaluation of antitumor activity of AZD3965 using in vivo.". Paper presented in 6th Annual ISCaM Meeting 2019, 2019.
  8. Julieta Afonso; Ricardo Marques; Catarina Barbosa-Matos; Martin Michaelis; Adhemar Longatto; Lúcio Santos; Jindrich Cinatl Jr; et al. "Cisplatin-resistant urothelial bladder cancer cells undergo metabolic reprogramming.". Paper presented in 26th Porto Cancer Meeting and 5th Joint Meeting Porto-Bordeaux, 2019.
  9. Sofia Oliveira-Pinto; Olívia Pontes; Belém Sampaio-Marques; Paula Ludovico; Fernanda Proença; Baltazar, F; Marta Costa. "Novas moléculas baseadas na unidade de cromeno como candidatas à terapia do carcinoma das células renais (CCR).". Paper presented in 1º Encontro Nacional de Jovens Investigadores em Oncologia, IPO – Porto (Portugal), 2019.
  10. Luísa Carvalho; Sofia Oliveira-Pinto; Olívia Pontes; Diogo Lopes; Beatriz Ferreira; M. Fernanda Proença; Baltazar, F; Marta Costa. "Síntese e atividade biológica de novos agentes anticancerígenos para o tratamento do cancro da mama.". Paper presented in 1º Encontro Nacional de Jovens Investigadores em Oncologia, IPO – Porto (Portugal), 2019.
  11. Olívia Pontes; Belém Sampaio-Marques; Sara Duarte-Silva; Carlos Bessa; Paula Ludovico; Patrícia Maciel; Baltazar, F; Fernanda Proença; Marta Costa. "Exploitation of novel chromene derivatives for breast cancer treatment.". Paper presented in 1º Encontro Nacional de Jovens Investigadores em Oncologia, IPO – Porto (Portugal), September 2019, 2019.
  12. Sofia Oliveira-Pinto; Olívia Pontes; Belém Sampaio-Marques; Paula Ludovico; Fernanda Proença; Baltazar, F; Marta Costa. "Chromene-based compounds as candidates for renal cell cancer treatment.". Paper presented in RICT2019: 55th International Conference on Medicinal Chemistry, Nantes (France), 2019.
  13. Olívia Pontes; Belém Sampaio-Marques; Sara Duarte-Silva; Carlos Bessa; Paula Ludovico; Patrícia Maciel; Baltazar, F; et al. "New chromene derivatives: Unraveling the molecular mechanisms for breast cancer therapy.". Paper presented in 13th Biological and Medicinal Chemistry Postgraduate Symposium, Cambridge (United Kingdom), 2019.
  14. Bertão AR; Vilac¸a N; Granja S; Marta Costa; Parpot P; Fonseca AM; Ban~obre-Lo´pez M; Baltazar, F; Neves IC. "In vitro and in vivo efficacy evaluation of drug delivery systems based on zeolites.". Paper presented in Nanomed Europe, 2019.
  15. Diogo Lopes; Sofia Oliveira-Pinto; João Louçano; Baltazar, F; Marta Costa; M. Fernanda Proença. "Synthesis of functionalized chromeno[2,3-b]pyridines: promising agents for breast cancer treatment.". Paper presented in 4th Symposium on Medicinal Chemistry, University of Minho, 2019.
  16. Sofia Oliveira-Pinto; Olívia Pontes; Belém Sampaio-Marques; Paula Ludovico; Fernanda Proença; Baltazar, F; Marta Costa. "Biological activity of novel targeted inhibitors for renal cell cancer therapy.". Paper presented in 26th Porto Cancer Meeting and 5th Joint Meeting Porto-Bordeaux, 2019.
  17. Olívia Pontes; Belém Sampaio-Marques; Sara Duarte-Silva; Carlos Bessa; Paula Ludovico; Patrícia Maciel; Fernanda Proença; Baltazar, F; Marta Costa. "In vitro and in vivo evaluation of new chromene derivatives as potent anticancer agents.". Paper presented in 26th Porto Cancer Meeting and 5th Joint Meeting Porto-Bordeaux, 2019.
    10.1158/1538-8514.pi3k14-b24
  18. Sara Gomes; Jorge Macedo; Maria João Azevedo; Susana Chaves; Elisabete Silva; Baltazar, F; Ana Preto. "Uncovering the role of acetate in the prevention of colorectal cancer induced by food contaminants.". Paper presented in 26th Porto Cancer Meeting and 5th Joint Meeting Porto-Bordeaux, 2019.
  19. Joana Pereira-Vieira; Sara Granja; Catarina Matos-Barbosa; Young H Ko; Ana Preto; Margarida Casal; Baltazar, F; Baltazar, F. "3-Bromopyruvate pre-treatment sensitizes MOLM13 and KG-1 cell lines to chemotherapy.". Paper presented in 6th Annual ISCaM Meeting 2019, 2019.
  20. Sofia Oliveira-Pinto; Olívia Pontes; Fernanda Proença; Baltazar, F; Marta Costa. "Chromene-based molecules as targeted inhibitors for renal cell cancer therapy.". Paper presented in ICVS Open Week, Braga (Portugal), 2019.
  21. Olívia Pontes; Marta Costa; Tatiana Dias; Filipa Santos; Belém Sampaio-Marques; Baltazar, F; M. Fernanda Proença. "New chromene-based molecules as microtubule destabilizers and pro-apoptotic agents in cancer". Paper presented in Making it Personal: Cancer Precision Medicine, Bergamo (Italy), 2018.
  22. P.R. Correia; C. Almeida-Aguiar; A.M. Fonseca; Baltazar, F; I.C. Neves. "Dual Nanomaterial Systems Aiming Antimicrobial Activity and Cancer Treatment". Paper presented in 13th International Chemical and Biological Engineering Conference (CHEMPOR 2018), Aveiro (Portugal), 2018.
  23. Sara Gomes; Sara Granja; Baltazar, F; Ana Preto. "The role of acetate in oncogene signalling activation and metabolism in colorectal cancer.". Paper presented in IV Symposium of the Doctoral Program on Molecular and Environmental Biology (PDBMA), Braga (Uminho), 2018.
  24. Diana Sousa; Baltazar, F; Lígia R. Rodrigues. "Targeting oncogenic microRNAs in Triple Negative Breast Cancer using CRISPR/cas9 approach.". Paper presented in MIT Portugal Annual Conference - Lisbon, 2018.
  25. Olívia Pontes; Marta Costa; Filipa Santos; Belém Sampaio-Marques; Paula Ludovico; Baltazar, F; Fernanda Proença. "Chemical and biological characterization of chalcones and 4H-chromenes: exploitation as anticancer agents.". Paper presented in 3rd ASPIC International Congress, Lisbon (Portugal), 2018.
  26. Murilo Bonatelli; Erica Aparecida de Oliveira; Silvya Stuchi Maria-Engler; Baltazar, F; Vinicius de Lima Vazquez; Céline Pinheiro. "Metabolic characterization and 3-bromopyruvate sensitivity screening in 12 melanoma cell lines.". Paper presented in Annual GAP Conference 2018 “Global efforts fighting cancer”, Stockholm (Sweden), 2018.
  27. Sara Gomes; Sara Granja; Baltazar, F; Ana Preto. "Uncovering the role of acetate in the crosstalk between monocarboxylate transporters and oncogene signaling pathways in colorectal cancer". Paper presented in 3rd ASPIC International Congress, Lisbon (Portugal), 2018.
  28. Olívia Pontes; Marta Costa; Filipa Santos; Belém Sampaio-Marques; Paula Ludovico; Fernanda Proença; Baltazar, F. "Discovery of chromene-based molecules as apoptosis-inducers by G2/M cell-arrest.". Paper presented in 25th Porto Cancer Meeting, Porto (Portugal), 2018.
  29. Nathalia Ferreira; Baltazar, F; Sara Granja; Ricardo Silvestre. "Elucidating the impact of IL-17A/F in lung cancer". Paper presented in 25th Porto Cancer Meeting, Porto (Portugal), 2018.
  30. Olívia Pontes; Marta Costa; Filipa Santos; Belém Sampaio-Marques; Paula Ludovico; Fernanda Proença; Baltazar, F. "Unraveling the anticancer molecular mechanisms of new chromene-based drugs.". Paper presented in ICVS Open Week, Braga (Portugal), 2018.
  31. Natália Noronha Ferreira; Edenir Rodrigues Pereira Filho; Baltazar, F; Maria Palmira Daflon Gremião. "Factorial design to optimize PLGA-chitosan polymeric nanoparticles development for Alpha-cyano-4-hydroxycinnamate (CHC) release through the nasal route.". Paper presented in 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada (Spain), 2018.
  32. Olívia Pontes; Marta Costa; Filipa Santos; Belém Sampaio-Marques; Paula Ludovico; Baltazar, F; Fernanda Proença. "Chromene-based drug candidates for cancer treatment.". Paper presented in 12th National Organic Chemistry Meeting and 5th National Medicinal Chemistry Meeting, Coimbra (Portugal), 2018.
  33. Nunes, AP; Ferreira, H; Neves M Nuno; Baltazar, F; Granja, S.. "Targeting Cancer Cell Metabolism Using Targeted Drug Delivery Systems". Paper presented in 25th Porto Cancer meeting, 2018.
  34. Priscila B. Campos; Claudia P. Oliveira; José Tadeu Stefano; Aline L. Chagas; Paulo Herman; Luiz C. D’albuquerque; Mário R. Alvares da Silva; et al.. "Hepatocellular carcinoma in non-alcoholic steatohepatitis (NASH): Clinical, histopathological aspects and immunohistochemical of metabolic and proliferative related-markers.". 2017.
  35. Priscila B. Campos; Claudia P. Oliveira; José Tadeu Stefano; Aline L. Chagas; Paulo Herman; Luiz C. D’albuquerque; Mário R. Alvares da Silva; et al. "Hepatocellular carcinoma in non-alcoholic steatohepatitis (NASH) – Clinical, histopathological aspects and immunohistochemical aspects". Paper presented in International Liver Cancer Association (ILCA), 11th Annual Conference, Seoul, South Korea, 2017.
  36. N Vilaça; AM Fonseca; Baltazar, F; IC Neves. "Encapsulation of 5-Fuoruracil into porous nanostructures for in vitro models of solid tumors". Paper presented in 21st International Symposium on Microencapsulation, Faro (Portugal), 2017.
  37. Ana Margarida Barbosa; Catarina M. Ferreira; Inês Mesquita; Inês Pereira; Adhemar Longatto-Filho; Agostinho Carvalho; Ricardo Silvestre; et al. "Dietary zinc supplementation promotes tumor overgrowth through a microbiota-tumor axis". Paper presented in XLIII SPI Annual Meeting, I3S, Porto, 2017.
  38. Olívia Pontes; Marta Costa; Filipa Santos; Sara Granja; Baltazar, F; M. Fernanda Proença. "New chromene-based drug candidates for cancer treatment". Paper presented in I Simpósio em Bioquímica Aplicada, University of Minho, Braga, 2017.
  39. Joa~o Azevedo-Silva; Cla´udia S. F. Oliveira; Odi´lia Queiro´s; Manuela Co^rte-Real; Baltazar, F; Young Hee Ko; Peter L. Pedersen; Ana Preto; Margarida Casal. "Transport of short chain fatty acids and 3-bromopyruvate in cancer cells: implications for cancer therapy". Paper presented in XIX Congresso Nacional da Sociedade Portuguesa de Bioquímica, Guimarãres (Portugal), 2016.
  40. Olga Martinho; Renato Silva-Oliveira; Fernanda Cury; Ana Martins Barbosa; Sara Granja; Adriane Feijó Evangelista; Fábio Marques; et al. "Blocking glucose metabolism enhances the effect of HER inhibitors in cervical cancer therapy". Paper presented in XIX Congresso Nacional da Sociedade Portuguesa de Bioquímica, Guimarãres (Portugal), 2016.
  41. Sara Granja; João Azevedo-Silva; Odília Queirós; Ana Preto; Baltazar, F; Margarida Casal. "Targeting glycolysis in acute myeloid leukemia: therapeutic applications.". Paper presented in XIX Congresso Nacional da Sociedade Portuguesa de Bioquímica, Guimarãres (Portugal), 2016.
  42. Baltazar, F; António Gil Castro; José Miguel Pêgo; Margarida Correia-Neves; Alexandra Miranda; Carlos Capela; Nuno Sousa; Manuel João Costa; Jorge Pedrosa. "Student success and perception of subject knowledge of an integrated course on the essentials of disease and treatment". Paper presented in CNIEM 2016- Congresso Nacional de Investigação em Educação Médica, Covilhã (Portugal), 2016.
  43. Baltazar, F; António Gil Castro; Carlos Capela; Margarida Correia-Neves; José Miguel Pêgo; Manuel João Costa. "An integrated course on the essential concepts of disease and treatment: longitudinal findings on acceptability and retention of disciplinary knowledge". Paper presented in The Association for Medical Education in Europe (AMEE) 2016, Barcelona (Spain), 2016.
  44. Azevedo-Silva, J.; Oliveira, CSF; Queirós, O; Ribas, D; Côrte-Real, M; Baltazar, F; Goffeau, A; et al. "Transport of monocarboxylic acids in cancer cells: implications of short chain fatty acids and 3-bromopyruvate for cancer therapy.". Paper presented in SMYTE 34, Chania, Crete, Greece, 2016.
  45. Eduardo Caetano Albino da Silva; Flavio Mavignier Cárcano; Baltazar, F; Luiz Fernando Lopes; Cristovam Scapulatempo Neto; Céline Pinheiro. "The clinicopathological significance of monocarboxylate transporters (MCTs) and CD147 in germ cell tumors". Paper presented in 4th International Conference on Tumor Microenvironment and Cellular Stress: Signaling, Metabolism, Imaging and Therapeutic Targets, June 5-10th 2016, Rhodes, Greece, 2016.
  46. N Vilaça; F Santos; R Amorim; R Totovao; E Prasetyanto; AM Fonseca; L De Cola; Baltazar, F; IC Neves. "Internalization and cytotoxicity of zeolytes as carriers for celular delivery". Paper presented in 10º Encontro Nacional de Catálise e Materiais Porosos (X ENCMP), May 19-20th 2016, Lisbon, Portugal., 2016.
  47. Natália Vilaça; Filipa Santos; Ricardo Amorim; António M. Fonseca; Isabel C. Neves; Baltazar, F. "Effect of surface functionalization of zeolite L on cellular uptake in breast cancer and epithelial mammary cells". Paper presented in 2nd ASPIC International Congress, 2016, IPO-Porto, April 28-29th Porto, Portugal, 2016.
  48. Olívia Pontes; Marta Costa; Filipa Santos; M. Fernanda Proença; Baltazar, F. "Chromene derivatives as anticancer agents: synthesis and biological evaluation.". Paper presented in 2nd ASPIC International Congress, 2016, IPO-Porto, April 28-29th Porto, Portugal, 2016.
  49. Azevedo-Silva, J.; Queirós, O.; Ribeiro, A; Baltazar, F; Ko YH; Petersen PL; Preto, A.; Casal, Margarida. "The extracellular pH influences the cytotoxicity and transport of 3-Bromopyruvate in breast cancer cells". Paper presented in 2nd ASPIC International Congress, 2016, IPO-Porto, 2016.
  50. N Vilaça; F Santos; R Amorim; R Totovao; E Prasetyanto; AM Fonseca; L De Cola; Baltazar, F; IC Neves. "Internalization and cytotoxicity of zeolytes on breast cancer cell lines". Paper presented in AFM BioMed Conference, April 11-15th 2016, Porto, Portugal, 2016.
  51. Filipa Morais-Santos; Sara Granja; Vera Miranda-Gonçalves; António H.J. Moreira; João L. Vilaça; Joana Paredes; Fernando C. Schmitt; Baltazar, F; Céline Pinheiro. "Targeting lactate transport suppresses in vivo breast tumor growth". Paper presented in ISCaM meeting - Metabolism and Microenvironment in cancer plasticity, Venice, Italy, 2015.
  52. Sara Granja; Céline Pinheiro; Adhemar Longatto-Filho; Madson Q. Almeida; André M. Faria; Maria Candida B. V. Fragoso; Silvena Maria Lovisolo; et al. "The Warburg effect:¿a new relevant road in the biology of adrenocortical tumors in adults". Paper presented in 2nd ISCaM meeting - Metabolism and Microenvironment in cancer plasticity, Venice, Italy, 2015.
  53. Ricardo Amorim; Ana Preto; Baltazar, F. "Lactate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.". Paper presented in 2nd ISCaM meeting - Metabolism and Microenvironment in cancer plasticity, Venice, Italy, 2015.
  54. Pinheiro C; Miranda-Gonçalves V; Longatto-Filho A; Scapulatempo C; Viana CR; Almeida AV; Reis RM; Baltazar, F; Vazquez VL. "The metabolic microenvironment of melanomas: prognostic value of MCT4". Paper presented in MD Anderson Young Investigators Workshop 2015, Oslo, Norway, 2015.
  55. Ana Marques; Sara Granja; Ana Ferreira; Ana Silva; Sónia Vilaça; Herlander Marques; Baltazar, F. "Increased expression of monocarcboxylate transporters 1 and 4 and carbonic anhydrase IX in pancreatic ductal adenocarcinomas". Paper presented in ESMO 17th world congress gastrointestinal cancer, Barcelona (Spain), 2015.
  56. Suellen Ferro; Helena Pereira; Sara Alves; Lisandra Castro; Baltazar, F; Susana Chaves; Manuela Côrte-Real; Ana Preto. "Cathepsin D is involved in the degradation of damaged mitochondria during acetate-induced apoptosis in colorectal cancer cells.". Paper presented in XXIII Porto Cancer Meeting - Stem Cells and Cancer, 2015.
  57. Marta Costa; Filipa Santos; Alexandra Brito; Ângela Fernandes; Maria Azevedo; Paula Ludovico; Bruno Costa; M. Fernanda Proença; Baltazar, F. "Anticancer profile of a selection of new chromene-based compounds". Paper presented in XXIII Porto Cancer Meeting - Stem Cells and Cancer, 2015.
  58. Vera Miranda-Gonçalves; Mrinalini Honavar; Manuel M. Pires; Célia Pinheiro; Michelle Cordeiro; Gil Bebiano; Paulo Costa; Rui M. Reis; Baltazar, F. "Monocarboxylate Transporter 1 (MCT1) expression at hypoxic conditions in glioblastomas: functional role and regulation". Paper presented in XXIII Porto Cancer Meeting - Stem Cells and Cancer, 2015.
  59. Sara Granja; Céline Pinheiro; Adhemar Longatto-Filho; Madson Q. Almeida; André M. Faria; Maria Candida B. V. Fragoso; Silvena Maria Lovisolo; et al. "The Warburg effect: a new relevant road in the biology of adrenocortical tumors in adults". Paper presented in XXIII Porto Cancer Meeting - Stem Cells and Cancer, 2015.
  60. J Afonso; LL Santos; A Morais; T Amaro; A Longatto-Filho; Baltazar, F. "The metabolic coupling among urothelial bladder cancer compartments predicts tumour aggressiveness and chemoresistance". Paper presented in XXIII Porto Cancer Meeting - Stem Cells and Cancer, 2015.
  61. Filipa Morais-Santos; Sara Granja; Vera Miranda-Gonçalves; António H.J. Moreira; João L. Vilaça; Joana Paredes; Fernando C. Schmitt; Baltazar, F; Céline Pinheiro. "Targeting lactate transport suppresses in vivo breast tumor growth". Paper presented in XXIII Porto Cancer Meeting - Stem Cells and Cancer, 2015.
  62. Baltazar, F; António Gil Castro; Manuel João Costa; Jorge Pedrosa; Margarida Correia-Neves. "Learning bacterial identification in infectious disease using a laboratory guided discovery approach". Paper presented in 2º Seminário do NEIP - INOVAÇÃO PEDAGÓGICA NO ENSINO SUPERIOR, University of Minho - Instituto de Educação, 2015.
  63. Suellen Ferro; Helena Pereira; Sara Alves; Lisandra Castro; Baltazar, F; Susana Chaves; Ana Preto; Manuela Côrte-Real. "Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria". Paper presented in XXXIX Jornadas Portuguesas da Genética, 2015.
  64. João Azevedo-Silva; Baltazar, F; Young H. Ko; Peter Petersen; Ana Preto; Margarida Casal. "Silencing of Monocarboxylate transporters as a tool to study the role of 3-bromopyruvate in breast cancer". Paper presented in XXXIX Jornadas Portuguesas da Genética, 2015.
  65. Silva-Carvalho R; Miranda-Gonçalves V; Ferreira AM; Cardoso SM; Sobral AJFN; Almeida-Aguiar C; Baltazar, F. "Caraterização da actividade antitumoral e angiogénica do própolis português usando modelos in vitro e in vivo.". Paper presented in III Congresso Ibérico de Apicultura, 13-15 abril 2014, Mirandela, Portugal, 2014.
  66. Marques RA; Baltazar, F; Cunha, A; R Oliveira; Almeida-Aguiar C. "Análise dos mecanismos de actividade biológica do própolis do Pereiro.". Paper presented in III Congresso Ibérico de Apicultura, 13-15 abril 2014, Mirandela, Portugal, 2014.
  67. Martins D; Beça FF; B Sousa; Baltazar, F; Paredes J; Schmitt F. "Loss of caveolin-1 and gain of MCT4 expression in the tumour stroma: key events in the progression from an in situ invasive breast carcinoma". Paper presented in GCGC, 19-20 setembro 2013, Lisboa., 2013.
  68. Valente D; Pinheiro C; Baltazar, F; Moreira R; Queirós O. "Multidrug resistance phenotype: pH regulation in breast cancer cells". Paper presented in EMBO Young Scientists Forum- Lisbon, julho 2013, Lisboa, 2013.
  69. Machado AF; Amorim R; Morais-Santos F; Parpot P; Pereira MFR; Fonseca AM; Baltazar, F; Neves IC. "An experimental study of 5-fluorouracil encapsulated in nanoporosity of zeolite structures as carriers for drug delivery". Paper presented in 1st Symposium on Medicinal Chemistry, 17 maio 2013, University of Minho, Braga, 2013.
  70. Machado AF; Santosa JD; Neto P; Amorim R; Morais-Santos F; Parpot P; Pereira MFR; et al. "Drug delivery systems based on zeolites". Paper presented in 9º Encontro Nacional da Divisão de Catálise e Materiais Porosos, 6 a 7 de maio de 2013 Porto, Portugal., 2013.
    10.1364/acpc.2013.ath3l.1
  71. S Sousa; Miranda-Gonçalves V; Pértega-Gomes N; Vizcaíno JR; Jerónimo C; Lopes C; Henrique R; Baltazar, F. "The effect of MCT1 and MCT4 downregulation on prostate cancer survival and aggressiveness". Paper presented in XXII Porto Cancer Meeting, 11-12 abril 2013, Porto, Portugal, 2013.
  72. R Carvalho; Valença I; Ferreira AM; Aguiar CA; Baltazar, F. "Characterization of the Antitumoral Activity of Portuguese Propolis.". Paper presented in XXII Porto Cancer Meeting, 11-12 abril 2013, Porto, Portugal, 2013.
  73. Bezerra F; Cunha M; Pinheiro C; Baltazar, F. "Monocarboxylate transporters as mediators in tumor-endothelial cell crosstalk". Paper presented in XXII Porto Cancer Meeting, 11-12 abril 2013, Porto, Portugal, 2013.
  74. Afonso J; Longatto-Filho A; Miranda-Gonçalves V; N Sousa; Morais A; Amaro T; Santos LL; Baltazar, F. "CD147 and MCT1 – Potential partners in bladder cancer aggressiveness and chemoresistance". Paper presented in XXII Porto Cancer Meeting, 11-12 abril 2013, Porto, Portugal, 2013.
  75. Morais-Santos F; Pinheiro C; A Vieira; Paredes J; Schmitt FC; Baltazar, F. "Exploitation of Monocarboxylate Transporter 1 (MCT1) as target in breast cancer therapy". Paper presented in XXII Porto Cancer Meeting, 11-12 abril 2013, Porto, Portugal, 2013.
  76. Machado AF; Amorim R; Morais-Santos F; Parpot P; Fonseca AM; Neves IC; Baltazar, F. "Potentiation of 5-fluorouracil entrapped in zeolite as drug delivery systems for in vitro models of coloretal and breast carcinomas". Paper presented in XXII Porto Cancer Meeting, 11-12 abril 2013, Porto, Portugal, 2013.
  77. B Sousa; Ribeiro AS; Nobre AR; N Lopes; Martins D; Pinheiro C; Vieira AF; et al. "Aberrant P-cadherin expression in breast câncer is associated with hypoxic, glycolytic and acid-resistant tumour phenotypes". Paper presented in XXII Porto Cancer Meeting, 11-12 abril 2013, Porto, Portugal, 2013.
  78. Martins D; Beça FF; B Sousa; Baltazar, F; Paredes J; Schmitt F. "Loss of caveolin-1 and gain of MCT4 expression in the tumour stroma: key events in the progression from an in situ an invasive breast carcinoma". Paper presented in XXII Porto Cancer Meeting, 11-12 abril 2013, Porto, Portugal, 2013.
  79. Morais-Santos F; Pinheiro C; A Vieira; Paredes J; Schmitt FC; Baltazar, F. "Contribution of Monocarboxylate Transporters to the Aggressive Phenotype of Breast Cancer". Paper presented in 11th International Congress on Targeted Anticancer Therapies, TAT meeting 2013, Março 2013, Paris, França, 2013.
  80. Granja S; Marchiq I; Le Floch R; Baltazar, F; Pouysségur J. "Targeting CD147/Basigin sensitizes A549 lung carcinoma cells to Phenformin". Paper presented in TAT meeting 2013, Março 2013, Paris, França, 2013.
  81. Granja S; Marchiq I; Le Floch R; Baltazar, F; Pouysségur J. "Targeting CD147/Basigin sensitizes A549 lung carcinoma cells to Phenformin.". Paper presented in Advances in Molecular Oncology: Translating Molecular Biology into Cancer Treatment, fevereiro 2013, São Paulo, Brasil., 2013.
  82. Ricardo R; Vilaça N; Fonseca AM Neves IC; Baltazar, F. "Zeolites as suitable Drug Delivery Systems for anticancer drugs in in vitro models of colorectal carcinoma". Paper presented in SPSAS - Advances in Molecular Oncology: Translating Molecular Biology into Cancer Treatment, fevereiro 2013, São Paulo, Brasil., 2013.
  83. Morais-Santos F; Pinheiro C; A Vieira; Paredes J; Schmitt FC; Baltazar, F. "Monocarboxylate Transporters as therapeutic targets in breast cancer.". Paper presented in Advances in Molecular Oncology: Translating Molecular Biology into Cancer Treatment, 2013, São Paulo, Brasil., 2013.
  84. Miranda-Gonçalves V; Honavar M; Pinheiro C; Martinho O; Reis RM; Baltazar, F. "MCT1 plasma membrane expression is associated to hypoxic regions in glioblastomas". Paper presented in EACR-22, julho 2012, Barcelona, Espanha, 2012.
  85. Pértega-Gomes N; Vizcaíno JR; Lopes C; Baltazar, F. "Metabolic phenotypes associated with distinct androgen-responsive conditions can be a valuable tool for diagnostic and therapeutic options in prostate cancer". Paper presented in A one day symposium with Carlos Caldas sponsored by EACR, 29 outubro 2012, Porto., 2012.
  86. Pértega-Gomes N; Vizcaíno JR; Lopes C; Baltazar, F. "Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transportes (MCTs).". Paper presented in São Paulo Advanced School of Comparative Oncology, 30 setembro a 6 de outubro 2012, Águas de São Pedro, S. Paulo, Brasil, 2012.
  87. Valença I; Pértega-Gomes N; Cunha M; Jerónimo C; Almeida-Aguiar C; Baltazar, F. "Portuguese propolis decreases PC-3 cell glycolytic metabolism". Paper presented in II International Symposium on Bee Products, 9-12 setembro 2012, Bragança, Portugal., 2012.
  88. Vieira de Castro, Joana; Martinho O; Miranda-Gonçalves V; Baltazar, F; Reis RM. "Role of glioblastoma cell metabolism in response to anti-RTK therapy.". Paper presented in EACR22, 7 to 10 July 2012, Barcelona, Espanha, 2012.
  89. Pinheiro C; Morais-Santos F; Miranda-Gonçalves V; Boccardo E; Lepique AP; Longatto-Filho A; Villa LL; Baltazar, F. "Role of monocarboxylate transporters (MCTs) in the regulation of the metabolic profile of cervical cancer cells by hypoxia.". Paper presented in EACR-22, 2012, julho 2012, Barcelona, Espanha, 2012.
  90. Pinheiro C; Morais-Santos F; Miranda-Gonçalves V; Pinheiro S; Boccardo E; Lepique AP; Longatto-Filho A; Villa LL; Baltazar, F. "Exploring the “Warburg effect” for cancer therapy: targeting lactate transport in cervical cancer". Paper presented in EACR-22, 2012, julho 2012, Barcelona, Espanha, 2012.
  91. Morais-Santos F; Pinheiro C; Miranda-Gonçalves V; A Vieira; Paredes J; Schmitt FC; Baltazar, F. "Regulation of the metabolic profile of breast cancer cells by hypoxia". Paper presented in EACR-22, 2012, julho 2012, Barcelona, Espanha, 2012.
  92. Amorim R; Vilaça N; Fonseca AM; Neves IC; Preto A; Baltazar, F. "Enhancing 5-FU activity in colorectal carcinoma-derived cell lines: combination with monocarboxylate transporter inhibitors and encapsulation into zeolites". Paper presented in EACR-22 - from Basic Research to Personalised Cancer Treatment, julho 2012, Barcelona, Espanha, 2012.
  93. Pértega-Gomes N; Vizcaíno JR; Lopes C; Baltazar, F. "Tracing the metabolic profile of prostate cancer progression. Roles for monocarboxylate transporters (MCTs) in prostate cancer metabolism". Paper presented in EACR-22 - from Basic Research to Personalised Cancer Treatment, julho 2012, Barcelona, Espanha, 2012.
  94. Vilaça N; Amorim R; Baltazar, F; Fonseca AM; Neves IC. "Zeolites: Promising candidates for drug delivery systems (DDSs).". Paper presented in Vth International Conference on Molecular Materials. MOLMAT 2012 -3-6 de julho 2012 Barcelona, Espanha., 2012.
  95. Vilaça N; Amorim R; Baltazar, F; Fonseca AM; Neves IC. "Drug delivery systems for colorectal carcinoma treatment based on zeolites: a promising material". Paper presented in II Encontro TCAQ, Universidade do Minho, 8 de junho de 2012, Braga, Portugal., 2012.
  96. B Sousa; Ribeiro AS; N Lopes; Martins D; Albergaria A; Ricardo S; Vieira AF; et al. "Aberrant expression of the CSC marker P-cadherin is associated with hypoxic/ glycolytic and acid resistant phenotype in breast carcinomas". Paper presented in 7th Internacional Meeting of the Portuguese Society for Stem Cells and Cell Therapies, 26-27 abril 2012, Porto, Portugal., 2012.
  97. Vieira de Castro, Joana; Martinho O; Miranda-Gonçalves V; Baltazar, F; Reis RM. "Dissecting the role of glioblastoma cell metabolism in response to imatinib.". Paper presented in XXI Porto Cancer Meeting, 19-20 abril 2012, Porto, Portugal., 2012.
  98. Pértega-Gomes N; Vizcaíno JR; Lopes C; Baltazar, F. "Exploiting metabolic alterations in prostate cancer diagnosis and prognosis.". Paper presented in XXI Porto Cancer Meeting, 19-20 abril 2012, Porto, Portugal., 2012.
  99. Valente D; Pinheiro C; Baltazar, F; Casal, Margarida; Moreira R; Queirós O. "Molecular mechanisms underlying multidrug resistance in cancer cell lines: targeting cell metabolism and pH regulation". Paper presented in XXI Porto Cancer Meeting, abril 2012, Porto, Portugal., 2012.
  100. Pacheco A; Queirós O; Preto A; Pinheiro C; Azevedo-Silva J; Moreira R; Pedro M; Baltazar, F; Casal, Margarida. "Butyric acid increases monocarboxylate transportes (MCT) expression and enhances the cytotoxicity of the anti-tumoral agent 3-bromopyruvate (3-BP) in breast cancer cells.". Paper presented in XXI Porto Cancer Meeting, abril 2012, Porto, Portugal., 2012.
  101. Granja S; Marchiq I; Le Floch R; Baltazar, F; Pouysségur J. "Targeting CD147/Basigin in A549 lung carcinoma sensitizes these cells to Metformin". Paper presented in XXI Porto Cancer Meeting, abril 2012, Porto, Portugal., 2012.
  102. Pacheco A; Queirós, O; Preto A; Pinheiro C; Azevedo-Silva J; Moreira R; Pedro M; Baltazar, F; Casal, Margarida. "3-bromopyruvate cytotoxic effect in breast cancer cells is dependent of monocarboxylate transporters (MCT) expression and is enhanced by butyrate". Paper presented in Metabolism 2012. From signaling to disease, 2012, Heidelberg, Germany., 2012.
  103. Valente D; Cunha A; Pinheiro C; Baltazar, F; Moreira R; Queirós O. "Effect of efflux pumps expression and cell bioenergetics in the multidrug resistance phenotype in cancer cells". Paper presented in Metabolism 2012. From signaling to disease, 2012, Heidelberg, Germany., 2012.
  104. B Sousa; Ribeiro AS; N Lopes; Martins D; Albergaria A; Ricardo S; Vieira AF; et al. "Aberrant expression of the CSC marker P-cadherin is associated with hypoxic/ glycolytic and acid resistant phenotype in breast carcinomas". Paper presented in 7th International Meeting of the Portuguese Society for Stem Cells and Cellular Therapies (SPCE-TC), 2012, Porto, Portugal., 2012.
  105. Valença I; Cunha AC; Baltazar, F; Aguiar C. "Search for Portuguese propolis antimicrobial activity in a wide range of microorganisms.". Paper presented in MicroBiotec11, 1 a 3 dezembro 2011, Braga, Portugal, 2011.
  106. Cruz M; Valença I; Ribeiro C; Pereira J; Paulo J; Guimarães M; I Oliveira; et al. "Search for bioactivities in Portuguese propolis". Paper presented in iSci – Interface Ciência, 25 Novembro 2011, Braga, Portugal., 2011.
  107. Granja S; Rios E; Moura CS; Carneiro F; Baltazar, F. "Exploitating of Monocarboxylate transporters as therapeutic targets in lung cancer.". Paper presented in 39th meeting of ISOBM, October 2011 Florença, Itália, 2011.
  108. Miranda-Gonçalves V; Pertega-Gomes N; Lourenço T; Pinheiro C; Jerónimo J; Vizcaíno R.J; Lopes C; Baltazar, F. "Prostate cancer: exploitation of monocarboxylate transporters as potential therapeutic targets". Paper presented in 39th Meeting of the ISOBM, 2011, Florença, Itália., 2011.
  109. Morais-Santos F; Pinheiro C; A Vieira; Paredes J; Schmitt F; Baltazar, F. "Inhibition of glycolytic metabolism decreases the aggressiveness behavior of breast cancer cells". Paper presented in 39th Meeting of the ISOBM, 2011, Florença, Itália, 2011.
  110. Pinheiro C; Longatto-Filho A; Soares TR; Pereira H; Bedrossian C; Michael C; Schmitt F; Baltazar, F. "CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma". Paper presented in 39th Meeting of the ISOBM, 2011, Florença, Itália, 2011.
  111. Valença I; Ferreira AM; Aguiar C; Baltazar, F. "Portuguese Propolis Inhibits Tumor Cell Glycolytic Metabolism". Paper presented in APIMONDIA 2011 – 42nd International Apicultural Congress. Buenos Aires, Argentina, 21-25 setembro 2011, 2011.
  112. Sara Granja; Elisabete Rios; Conceição Souto Moura; Fátima Carneiro; Baltazar, F. "The role of Monocarboxylate transporters in lung cancer". Paper presented in XX Porto cancer meeting, Porto (Portugal), 2011.
  113. Ferreira AM; Cunha AC; Baltazar, F; Aguiar C; Ferreira, A. M.; Cunha, Ana; Baltazar, Fátima; Aguiar, Cristina. "Bioactivities of Portuguese Propolis". Paper presented in 1º Congresso Ibérico de Apicultura, 14-16 Abril 2011, Castelo Branco, Portugal, 2011.
  114. Miranda-Gonçalves V; Honavar M; Pinheiro C; Martinho O; Costa P; Reis RM; Baltazar, F. "Monocarboxylate transporters as potential therapeutic targets in glioblastomas.". Paper presented in XX Porto cancer meeting, 28-29 abril 2011, Porto., 2011.
  115. Valença I; I Oliveira; Morais-Santos F; Ferreira AM; Aguiar C; Baltazar, F. "Portuguese Propolis Inhibits Glycolytic Metabolism in the Colon Cancer Cell Line HCT-15". Paper presented in XX Porto cancer meeting, 28-29 abril 2011, Porto, 2011.
  116. Pértega-Gomes N; Vizcaíno JR; Lopes C; Baltazar, F. "Assessment of monocarboxylate transporters 1 and 4, CD147, CD44 and MDRI could help to predict biochemical recurrence in prostate cancer". Paper presented in XX Porto cancer meeting, 28-29 abril 2011, Porto., 2011.
  117. Amorim R; Pereira H; Preto A; Baltazar, F. "Monocarboxylate transporters – new molecular targets for colorectal carcinoma?". Paper presented in XX Porto cancer meeting, 28-29 abril 2011, Porto, 2011.
  118. Cunha C; Miranda-Gonçalves V; Martinho O; Baltazar, F. "Role of Monocarboxylate transporters in Angiogenesis.". Paper presented in XX Porto cancer meeting, 28-29 abril 2011, Porto., 2011.
  119. Morais-Santos F; Pinheiro C; A Vieira; Paredes J; Schmitt F; Baltazar, F. "Quercetin induces lactate transport inhibition in breast cancer cell lines". Paper presented in XX Porto cancer meeting, 28-29 abril 2011, Porto., 2011.
  120. Afonso J; Longatto-Filho A; Baltazar, F; N Sousa; Costa F; Morais A; Amaro T; Lopes C; L Santos. "CD147 overexpression allows an accurate discrimination of bladder cancer patients’ prognosis.". Paper presented in XX Porto cancer meeting, 28-29 abril 2011, Porto., 2011.
  121. Vilaça N; Amorim R; Martinho O; Reis RM; Baltazar, F; Fonseca AM; Neves IC. "Anticancer drugs encapsulated in zeolites.". Paper presented in VI International Materials Symposium MATERIAIS 2011 (XV meeting of SPM – Sociedade Portuguesa de Materiais) 18-20 abril 2011, Guimarães, Portugal., 2011.
  122. Amorim R; Martins S; Pereira H; Pinheiro C; Reis RM; Longatto-Filho A; Preto A; Baltazar, F. "Monocarboxylate transporters as new attractive targets for colorectal carcinoma therapy.". Paper presented in 2nd Symposium of the International Society for Proton Dynamics in Cancer (ISPDC), 2011, Nice, França., 2011.
  123. Miranda-Gonçalves V; Honavar M; Pinheiro C; Martinho O; Costa P; Reis M. R; Baltazar, F. "Targeting lactate transport activity in gliomas". Paper presented in 2nd Symposium of the International Society for Proton Dynamics in Cancer (ISPDC), 2011, Nice, França., 2011.
  124. Morais-Santos F; Pinheiro C; A Vieira; Paredes J; Schmitt F; Baltazar, F. "Treatment with Quercetin and Lonidamine decrease the aggressiveness behaviour of human breast cancer cells.". Paper presented in 2nd Symposium of the International Society for Proton Dynamics in Cancer (ISPDC), 2011, Nice, França., 2011.
  125. Granja S; Rios E; Moura CS; Carneiro F; Baltazar, F. "Monocarboxylate transporters as therapeutic targets in lung cancer.". Paper presented in 2nd Symposium of the International Society for Proton Dynamics in Cancer (ISPDC), 2011, Nice, França., 2011.
  126. Pértega-Gomes N; Vizcaíno JR; Lopes C; Baltazar, F. "Emerging roles for monocarboxylate transporters in prostate cancer metabolism.". Paper presented in 2nd Symposium of the International Society for Proton Dynamics in Cancer (ISPDC), 2011, Nice, França., 2011.
  127. Pértega-Gomes N; Vizcaíno JR; Lopes C; Baltazar, F. "Comparison of metabolic pathways between cancer and stromal cells in prostate carcinoma. A role of monocarboxylate transporters (MCTs) in tumour-stroma crosstalk.". Paper presented in FEBS Advanced Lecture Course on Translational Cancer Research, Algarve, Portugal., 2011.
  128. Pinheiro C; Pinheiro S; Boccardo E; Lepique AP; Longatto-Filho A; Villa LL; Baltazar, F. "Inhibition of monocarboxylate transporter 1 in cervical cancer cells: effect of alpha-cyano-4-hydroxycinnamate and siRNA.". Paper presented in 22nd EORTC-NCI-AACR symposium on “Molecular targets and Cancer Therapeutics”, 16-19 novembro 2010, Berlin, Alemanha, 2010.
  129. Miranda-Gonçalves V; Pinheiro C; Honavar M; Costa P; Reis RM; Baltazar, F. "Monocarboxylate transporter 1 as a potential therapeutic target in glioblastomas.". Paper presented in 22nd EORTC-NCI-AACR symposium on “Molecular targets and Cancer Therapeutics”, 16-19 novembro 2010, Berlim, Alemanha, 2010.
  130. Pinheiro C; Pinheiro S; Miranda-Gonçalves V; A Vieira; Paredes J; Schmitt F; Baltazar, F. "Targeting lactate transport in breast cancer cells: an attractive metabolic approach to fight cancer?". Paper presented in FEBS Workshop “Therapeutic Targets in Cancer Cell Metabolism & Death”, 23-26 outubro 2010, Capri, Itália., 2010.
  131. Pedro DFN; Ramos AA; Lima CF; Baltazar, F; Pereira-Wilson C. "Modulation of DNA Damage Prevention and Signaling Pathways in Diet Induced Colon Cancer Prevention.". Paper presented in The 16th International Charles Heidelberger Symposium on Cancer Research, 26-28 setembro 2010, Coimbra, Portugal, 2010.
  132. Pinheiro C; B Sousa; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar, F. "GLUT1 and CAIX expression profile in breast cancer correlate with MCT1 overexpression.". Paper presented in EACR21, 26-30 junho de 2010, Oslo, Noruega, 2010.
  133. Pedro DFN; Ramos AA; A Gomes; Collins AR; Baltazar, F; Pereira-Wilson C. "Is dietary modulation of DNA repair involved in colon cancer prevention?". Paper presented in XXXV Portuguese Genetics Conference, junho 2010, Braga, Portugal., 2010.
  134. A Miranda; Pinheiro S; S Costa; Baltazar, F; F Rodrigues; Portela C; Reis RM. "Association of Toll-like receptor 9 (TLR9) T-1237C gene polymorphism with breast cancer susceptibilitiy and prognosis". Paper presented in XXXV Portuguese Genetics Conference, junho 2010, Braga, Portugal., 2010.
  135. N Gomes; Vizcaíno JR; Miranda-Gonçalves V; Gouveia C; Lopes C; Baltazar, F. "Monocarboxylate transporter 2 as putative prostate cancer marker.". Paper presented in XIX Porto Cancer Meeting 22-23 abril 2010, IPATIMUP, Porto., 2010.
  136. Pinheiro C; Pinheiro S; Miranda-Gonçalves V; A Vieira; Paredes J; Schmitt F; Baltazar, F. "Sensitivity of breast cancer cells to CHC, an inhibitor of monocarboxylate transporter 1". Paper presented in XIX Porto Cancer Meeting 22-23 abril 2010, IPATIMUP, Porto., 2010.
  137. Miranda-Gonçalves V; Pinheiro C; Honavar M; Costa P; Baltazar, F; Reis RM. "MCT1 and its chaperone CD147 are upregulated in glioblastomas.". Paper presented in XIX Porto Cancer Meeting 22-23 abril 2010, IPATIMUP, Porto., 2010.
  138. Pinheiro S; Pinheiro C; A Vieira; Paredes J; Schmitt F; Baltazar, F. "Effect of oxamic acid on different breast carcinoma cell lines.". Paper presented in XIX Porto Cancer Meeting 22-23 abril 2010, IPATIMUP, Porto., 2010.
  139. Ramos AA; Pedro DFN; Baltazar, F; Collins AR; Pereira-Wilson C. "DNA damage as a biomarker of exposure to alkylating agents: Dietary chemoprevention of colon cancer through induction of MGMT". Paper presented in ECNIS International Workshop Biomarkers and Cancer, 21 setembro 2009, Porto, Portugal., 2009.
  140. Pinheiro C; Longatto-Filho A; Simoes K; Jacob Carlos Eduardo; Bresciani CJC; B Zilberstein; Cecconello I; et al. "The prognostic value of monocarboxylate transporters in gastric cancer". Paper presented in Joint 4th EORTC Pathobiology Group Annual Meeting & 1 st International Multidisciplinary Cancer Research Congress, 21-24 maio 2009, Turquia., 2009.
  141. Longatto-Filho A; Pinheiro C; Martinho O; Moreira MAR; Ribeiro LFJ; Queiroz GS; Schmitt FC; Baltazar, F; Reis RM. "The prognostic value of monocarboxylate transporters in gastric cancer". 2009.
  142. Pereira H; Pinheiro C; Xavier C; Pereira-Wilson C; Baltazar, F. "O ácido alfa-ciano-4-hidroxicinâmico (CHC) potencia o efeito citotóxico do 5-FU em linhas celulares de carcinoma do cólon". Paper presented in Encontros da Primavera – Oncologia 2009, 27-28 de março 2009, Évora, Portugal, 2009.
  143. N Gomes; Vizcaíno JR; Lopes C; Baltazar, F. "Monocarboxylate transporters 2 and 4 are upregulated in prostate cancer". Paper presented in European Congress of Pathology, 2009, Florença, Itália., 2009.
  144. Pinheiro C; Longatto-Filho A; Simoes K; Jacob CE; Bresciani CJC; B Zilberstein; Cecconello I; et al. "The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer". Paper presented in FEBS Advanced Lecture Course “Matrix Pathobiology, Signaling and Molecular Targets”, 2009, Patras, Grécia., 2009.
  145. Lima-Rodrigues M; Valle-Fernandes A; Lamas N; A Vieira; Nunes R; Pedrosa J; Castro AG; et al. "Possible alternative therapies to chronic laryngitis and laryngeal cancer: the use of COX-2 specific inhibitors.". Paper presented in EAORL-HNS 2009, Mannheim, Alemanha, 2009.
  146. Miranda-Gonçalves V; Pinheiro C; Honavar M; Costa P; Baltazar, F; Reis RM. "Potencial terapêutico de inibidores de MCTs em Glioblastomas". Paper presented in 2º Congresso Nacional da Associação Portuguesa de Neuro-Oncologia, 2009, Porto, Portugal., 2009.
  147. Simoes K; Longatto Filho A; Pinheiro C; Schmitt F; Ressio RA; Wakamatsu A; Baltazar, F; Alves V. "Increased apoptosis in gastric carcinogenesis progression can be influenced by mechanisms involved in tumoral microenvironment pH control.". Paper presented in XXVIIth International Congress of the International Academy of Pathology, 12-17 outubro 2008, Atenas, Grécia., 2008.
  148. Pinheiro C; Longatto A; Pereira SMM; Etlinger D; Moreira M; Jube L; Schmitt F; Baltazar, F. "CD147 expression correlates with monocarboxylate transporters 1 and 4 in cervical carcinoma". Paper presented in 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 21-24 outubro 2008, Genebra, Suiça, 2008.
  149. Pinheiro C; L Ferreira; B Sousa; Dufloth R; Vieira D; Schmitt F; Baltazar, F. "Monocarboxylate transporter 1 (MCT1) overexpression is associated with poor prognosis in breast carcinomas". Paper presented in 11th Cancer Research UK Beatson International Cancer Conference, 15-18 junho 2008, Glasgow, Escócia., 2008.
  150. Pinheiro C; Longatto-Filho A; Simoes K; L Ferreira; Alves AFV; Schmitt F; Baltazar, F. "Monocarboxylate transporter expression correlates with CD147 and HIF-1a in gastric cancer". Paper presented in 3rd Intercontinental Congress of Pathology, maio 2008, Barcelona, Espanha., 2008.
  151. S Costa; Longatto Filho A; Baltazar, F; Milanezi F; Schmitt FC. "Detection of Lymphatic Vessel Density by D2-40 in Ductal Invasive Breast Carcinomas.". Paper presented in 8th Euroconference on Angiogenesis, 9-12 maio 2008, Paris, França, 2008.
  152. Pinheiro C; L Ferreira; B Sousa; Dufloth R; Schmitt F; Baltazar, F. "MCT1 is upregulated in ER negative breast carcinomas.". Paper presented in CNIO-ONCOTRAIN, 10-11 março 2008, Madrid, Espanha, 2008.
  153. Pinheiro C; Longatto-Filho A; Moreira MAR; Queiroz GS; Oton GJB; Júnior AF; Ribeiro LFJ; Schmitt FC; Baltazar, F. "Altered expression of monocarboxylate transporters in pre-invasive and invasive lesions of the uterine cervix.". Paper presented in Eurogin 2007, 4-6 outubro 2007, Monte Carlo, Mónaco, 2007.
  154. Pinheiro C; Longatto-Filho A; L Ferreira; Scapulatempo C; Alves VAF; Pellerin L; Schmitt F; Baltazar, F. "Altered expression of monocarboxylate transporters 1, 2 and 4 in colorectal carcinomas". Paper presented in 21st European Congress of Pathology, 8-13 setembro 2007, Istambul, Turquia., 2007.
  155. Pinheiro C; Longatto-Filho A; L Ferreira; Scapulatempo C; Pellerin L; Alves VAF; Schmitt F; Baltazar, F. "Monocarboxylate transporters as new targets for colorectal cancer therapy?". Paper presented in 10th Cancer Research UK Beatson International Cancer Conference: Molecular Cancer Therapies: New Challenges and Horizons, 17-20 Junho 2007, Glasgow, Reino Unido., 2007.
  156. Lima-Rodrigues M; Valle-Fernandes A; Lamas N; A Vieira; Cruz A; Pedrosa J; Castro AG; et al. "Changes in the expression of inflammatory mediators and tumoral markers folowing neurogenic laryngitis: therapeutic trial with Etoricoxib". Paper presented in 10th Meeting of the Portuguese Society for Neurosciences, May 24-26 2007, Ofir, Portugal., 2007.
  157. Lima-Rodrigues M; Lamas N; A Vieira; Valle-Fernandes A; Baltazar, F; Reis RM; Cruz A; et al. "Changes in the Expression of Inflammatory Mediators following Neurogenic Laryngitis: therapeutic trial with etoricoxib". Paper presented in XXI Congresso da Sociedade Portuguesa de Microscopia, 14-15 Dezembro 2006, Braga, Portugal., 2006.
  158. Lima-Rodrigues M; A Vieira; Lamas N; Valle-Fernandes A; Baltazar, F; Reis RM; Almeida, A. "Chronic Neurogenic Inflammation and Laryngeal Cancer: possible chemoprevention effect of selective COX-2 inhibitors". Paper presented in XXI Congresso da Sociedade Portuguesa de Microscopia, 14-15 Dezembro 2006, Braga, Portugal., 2006.
  159. Longatto-Filho A; Costa SM; Baltazar, F; Milanezi F; Montruccoli D; Montruccoli GC; Schmitt F. "Imunohistochemical expression of VEGF-A and its ligands in non neoplastic lesions of the breast: correlation with dynamic angiothermography results". Paper presented in XVIII FIGO 2006 World Congress of Gynecology and Obstetrics Congress 5-10 novembro, Kuala Lumpur, Malásia., 2006.
  160. Longatto Filho A; Pinheiro C; Pereira SMM; Etlinger D; Baltazar, F; Schmitt FC. "Lymphatic vessel density in HPV-induced intraepithelial cervical lesions.". Paper presented in HPV and Cancer International Meeting, 9-10 novembro 2006, Turin, Itália., 2006.
  161. Pinheiro C; Baltazar, F; Longatto Filho A; Moreira MAR; Queiroz GS; Oton GJB; Júnior AF; Ribeiro LFJ; Schmitt FC. "Expression of the pro-inflammatory molecule COX-2 in different histological subtypes of cervix carcinomas: correlation with EGFR". Paper presented in SPI XXXII Annual Meeting, 13-14 Outubro 2006, Braga, Portugal, 2006.
  162. Lima-Rodrigues M; Valle-Fernandes A; Lamas N; A Vieira; Cruz A; Pedrosa J; Castro AG; et al. "Possible alternative therapies to chronic laryngitis and laryngeal cancer: the use of COX-2 specific inhibitors and detection of tumoral markers". Paper presented in SPI XXXII Annual Meeting, 13-14 Outubro 2006, Braga, Portugal., 2006.
  163. Reis-Filho JS; Pinheiro C; Lambros MBK; Milanezi F; Carvalho, S.; Savage K; Simpson PT; et al. "Recurrent EGFR amplification and lack of activating mutations in metaplastic breast carcinomas.". Paper presented in XXVI Congress of the International Academy of Pathology, 16-21 setembro, 2006, Montreal, Canadá, 2006.
  164. Reis-Filho JS; Pinheiro C; Lambros MBK; Milanezi F; S Carvalho; Savage K; Simpson PT; et al. "EGFR amplification and lack of activating mutations in metaplastic breast carcinomas". 2006.
    10.1002/path.2004
  165. Lima-Rodrigues M; Baltazar, F; Lamas N; Valle-Fernandes A; Nunes R; Reis RM; Milanezi F; Almeida, A. "Os inibidores da COX-2 podem ser importantes no tratamento da laringite crónica". Paper presented in 53rd National Congress of the Otorhinolaringology Head and Neck Surgery Portuguese Society, 20-23 Maio 2006, Granja, Portugal., 2006.
  166. Pinheiro C; Baltazar, F; Reis RM; Milanezi F; Reis-Filho JS; Schmitt FC. "Análise de alterações genéticas preditivas da resposta à terapêutica dirigida ao alvo molecular EGFR em carcinomas metaplásicos da mama". Paper presented in 9ª Reunião Científica Anual da SPGH e 3ª Reunião Científica Anual da Procura, 10 a 12 de Novembro de 2005, Cascais, Portugal., 2005.
  167. Fernandes RJ; Reis RM; Pinheiro C; Baltazar, F; Magalhães S; Santos LJ. "Análise de alterações genéticas preditivas da resposta à terapêutica dirigida ao alvo molecular EGFR em tumores de bexiga". Paper presented in 10º Congresso Nacional de Oncologia, 16 a 18 Outubro de 2005, Porto, Portugal., 2005.
  168. Macedo FYB; Mota JMSC; Almeida PRC; Baltazar, F; Schmitt F; Ferreira FV; Ribeiro, RA. "Expressão de COX-2 e papel dos inibidores de COX na cistite hemorrágica induzida por ifosfamida e seu metabolito acroleína". Paper presented in XX Reunião Anual da FeSBE, São Paulo (Brasil), 2005.
  169. Mota, JMSC; Macedo, FYB; Ferreira, FV; Ribeiro, RA; Almeida, PRC; Schmitt, F.; Baltazar, F. "Expressão de COX-2 e papel dos inibidores de COX na cistite hemorrágica (CH) induzida por ifosfamida (IFS) e seu metabolito acroleína (ACR)". Paper presented in Congresso Cearence de Cancerologia, 20-23 de abril de 2005, Fortaleza, Brasil, 2005.
  170. Guimarães-Soares L; Baltazar, F; Pascoal C; Cássio F. "Effects of heavy metals on mycelial growth, thiol content and protein secretion in the aquatic fungus Fontanospora fusiramosa". Paper presented in 22nd ESCPB Annual Conference, Alessandria, Itália, 2003.
Journal article
  1. Afonso J; Catarina Barbosa-Matos; Silvestre R; Joana Pereira Vieira; Samuel Martins Gonçalves; Camille Mendes-Alves; Pier Parpot; et al. "Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect". Cancers (2024): https://www.mdpi.com/2072-6694/16/7/1418.
    10.3390/cancers16071418
  2. Joana Pereira Vieira; Daniela Weber; Sâmia Silva; Catarina Barbosa-Matos; Sara Granja; Reis RM; Odilia Queiros; et al. "Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia". Pharmaceutics (2024): https://www.mdpi.com/1999-4923/16/4/442.
    10.3390/pharmaceutics16040442
  3. Ana Silva; Ana Félix; Mónica Cerqueira; Céline S. Gonçalves; Belém Sampaio-Marques; Adhemar Longatto-Filho; Fátima Baltazar; Julieta Afonso. "Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer". Pharmaceutics (2023): https://doi.org/10.3390/pharmaceutics15122688.
    10.3390/pharmaceutics15122688
  4. Ouissal Assila; Natália Vilaça; Ana R. Bertão; António M. Fonseca; Pier Parpot; Olívia S.G. P. Soares; Manuel F.R. Pereira; et al. "Optimization of iron-ZIF-8 catalysts for degradation of tartrazine in water by Fenton-like reaction". Chemosphere (2023): https://doi.org/10.1016/j.chemosphere.2023.139634.
    10.1016/j.chemosphere.2023.139634
  5. Diana Tavares-Valente; Stefania Cannone; Maria Raffaella Greco; Tiago Miguel Amaral Carvalho; Fátima Baltazar; Odília Queirós; Gennaro Agrimi; Stephan J. Reshkin; Rosa Angela Cardone. "Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell". Cancers (2023): https://doi.org/10.3390/cancers15153868.
    10.3390/cancers15153868
  6. Ana Rita Caetano; Rafaela Dias Oliveira; Sónia Pires Celeiro; Ana Sofia Freitas; Susana M. Cardoso; M. Sameiro T. Gonçalves; Fátima Baltazar; Cristina Almeida-Aguiar. "Phenolic Compounds Contribution to Portuguese Propolis Anti-Melanoma Activity". Molecules (2023): https://doi.org/10.3390/molecules28073107.
    10.3390/molecules28073107
  7. Ana Silva; Mónica Costa Cerqueira; Beatriz Rosa; Catarina Sobral; Filipa Pinto-Ribeiro; Marta Freitas Costa; Fátima Baltazar; Julieta Afonso. "Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms24065141.
    10.3390/ijms24065141
  8. Julieta Afonso; Céline Gonçalves; Marta Costa; Débora Ferreira; Lúcio Santos; Adhemar Longatto-Filho; Fátima Baltazar. "Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy". Cancers (2023): https://doi.org/10.3390/cancers15030982.
    10.3390/cancers15030982
  9. Shakiba GHOLAMI; Cintia CHAMORRO-PETRONACCI; Mario PÉREZ-SAYÁNS; José SUÁREZ PEÑARANDA; Adhemar LONGATTO-FILHO; Fátima BALTAZAR; Julieta AFONSO. "Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study". Journal of Applied Oral Science (2023): https://doi.org/10.1590/1678-7757-2022-0461.
    10.1590/1678-7757-2022-0461
  10. Bertao, AR; Guney, O; Costa, M; Fontao, P; Martinho, O; Costa, SPG; Fonseca, AM; et al. "Sustainable fluorescent dye-faujasite zeolite systems as tools for cancer bioimaging". CHEMICAL ENGINEERING JOURNAL (2023):
    10.1016/j.cej.2023.145109
  11. João C. C. Ferreira; Sara Granja; Ana F. Almeida; Fátima Baltazar; M. Sameiro T. Gonçalves; Ana Preto; Maria João Sousa. "Targeting Lysosomes in Colorectal Cancer: Exploring the Anticancer Activity of a New Benzo[a]phenoxazine Derivative". International Journal of Molecular Sciences (2022): https://doi.org/10.3390/ijms24010614.
    10.3390/ijms24010614
  12. Patrik da Silva Vital; Murilo Bonatelli; Marina Pereira Dias; Larissa Vedovato Vilela de Salis; Mariana Tomazini Pinto; Fátima Baltazar; Silvya Stuchi Maria-Engler; Céline Pinheiro. "3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells". International Journal of Molecular Sciences (2022): https://doi.org/10.3390/ijms232415650.
    10.3390/ijms232415650
  13. Sara Gomes; Fátima Baltazar; Elisabete Silva; Ana Preto. "Microbiota-Derived Short-Chain Fatty Acids: New Road in Colorectal Cancer Therapy". Pharmaceutics (2022): https://doi.org/10.3390/pharmaceutics14112359.
    10.3390/pharmaceutics14112359
  14. Ana Sofia Freitas; Marta Costa; Olívia Pontes; Veronique Seidel; Fernanda Proença; Susana M. Cardoso; Rui Oliveira; Fátima Baltazar; Cristina Almeida-Aguiar. "Selective Cytotoxicity of Portuguese Propolis Ethyl Acetate Fraction towards Renal Cancer Cells". Molecules (2022): https://doi.org/10.3390/molecules27134001.
    10.3390/molecules27134001
  15. Rafaela Dias Oliveira; Sónia Pires Celeiro; Catarina Barbosa-Matos; Ana Sofia Freitas; Susana M. Cardoso; Marta Viana-Pereira; Cristina Almeida-Aguiar; Fátima Baltazar. "Portuguese Propolis Antitumoral Activity in Melanoma Involves ROS Production and Induction of Apoptosis". Molecules (2022): https://doi.org/10.3390/molecules27113533.
    10.3390/molecules27113533
  16. Diana A. Sousa; Ricardo Gaspar; Celso J. O. Ferreira; Fátima Baltazar; Ligia R. Rodrigues; Bruno F. B. Silva. "In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome–DNA Complexes". Pharmaceutics (2022): https://doi.org/10.3390/pharmaceutics14051087.
    10.3390/pharmaceutics14051087
  17. Mónica Cerqueira; Efres Belmonte-Reche; Juan Gallo; Fátima Baltazar; Manuel Bañobre-López. "Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics". Pharmaceutics 14 3 (2022): 506-506. https://doi.org/10.3390/pharmaceutics14030506.
    10.3390/pharmaceutics14030506
  18. Sara Gomes; Catarina Teixeira-Guedes; Elisabete Silva; Fátima Baltazar; Ana Preto. "Colon microbiota modulation by dairy-derived diet: new strategy for prevention and treatment of colorectal cancer". Food & Function (2022): https://doi.org/10.1039/D2FO01720B.
    10.1039/D2FO01720B
  19. Ana Silva; Beatriz Antunes; Alberta Batista; Filipa Pinto-Ribeiro; Fátima Baltazar; Julieta Afonso. "In Vivo Anticancer Activity of AZD3965: A Systematic Review". Molecules (2021): https://doi.org/10.3390/molecules27010181.
    10.3390/molecules27010181
  20. Vera Miranda-Gonçalves; Céline S. Gonçalves; Sara Granja; Joana Vieira de Castro; Rui M. Reis; Bruno M. Costa; Fátima Baltazar. "MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma". Cancers 13 14 (2021): 3468-3468. https://doi.org/10.3390/cancers13143468.
    10.3390/cancers13143468
  21. Mariana Morais; Francisca Dias; Inês Nogueira; Anabela Leão; Nuno Gonçalves; Luís Araújo; Sara Granja; et al. "Cancer Cells’ Metabolism Dynamics in Renal Cell Carcinoma Patients’ Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186". Cancers 13 7 (2021): 1733-1733. https://doi.org/10.3390/cancers13071733.
    10.3390/cancers13071733
  22. Mario Pérez-Sayáns; Cintia M Chamorro-Petronacci; Fátima Baltazar; Fabio Ramoa Pires; Ángel Ínsua; Juan A Suárez-Quintanilla; José M Suárez-Peñaranda. "Nestin Expression Is Associated with Relapses in Head and Neck Lesions". Diagnostics 11 4 (2021): 583-583. https://doi.org/10.3390/diagnostics11040583.
    10.3390/diagnostics11040583
  23. Diana Tavares-Valente; Bárbara Sousa; Fernando Schmitt; Fátima Baltazar; Odília Queirós. Corresponding author: Fátima Baltazar. "Disruption of pH Dynamics Suppresses Proliferation and Potentiates Doxorubicin Cytotoxicity in Breast Cancer Cells". Pharmaceutics 13 2 (2021): 242-242. https://doi.org/10.3390/pharmaceutics13020242.
    10.3390/pharmaceutics13020242
  24. Natália N. Ferreira; Sara Granja; Fernanda I. Boni; Fabíola G. Prezotti; Leonardo M. B. Ferreira; Beatriz S. F. Cury; Rui M. Reis; Fátima Baltazar; Maria Palmira D. Gremião. "Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route". Drug Delivery and Translational Research 10 6 (2020): 1729-1747. https://doi.org/10.1007/s13346-020-00824-2.
    10.1007/s13346-020-00824-2
  25. Maria Manuel Azevedo; Cidália Pina-Vaz; Fátima Baltazar. "Microbes and Cancer: Friends or Faux?". International Journal of Molecular Sciences 21 9 (2020): 3115-3115. https://doi.org/10.3390/ijms21093115.
    10.3390/ijms21093115
  26. Julieta Afonso; Lúcio L. Santos; Adhemar Longatto-Filho; Fátima Baltazar. "Competitive glucose metabolism as a target to boost bladder cancer immunotherapy". Nature Reviews Urology (2020): https://doi.org/10.1038/s41585-019-0263-6.
    10.1038/s41585-019-0263-6
  27. Natália N. Ferreira; Sara Granja; Fernanda Isadora Boni; Leonardo M. B. Ferreira; Rui M. Reis; Fátima Baltazar; Maria Palmira D. Gremião. "A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems". Drug Delivery and Translational Research (2020): https://doi.org/10.1007/s13346-020-00713-8.
    10.1007/s13346-020-00713-8
  28. Miranda-Gonçalves, V.; Lameirinhas, A.; Henrique, R.; Baltazar, F.; Jerónimo, C.. "The metabolic landscape of urological cancers: New therapeutic perspectives". Cancer Letters 477 (2020): 76-87. http://www.scopus.com/inward/record.url?eid=2-s2.0-85081219698&partnerID=MN8TOARS.
    10.1016/j.canlet.2020.02.034
  29. Riera-Domingo, C.; Audigé, A.; Granja, S.; Cheng, W.-C.; Ho, P.-C.; Baltazar, F.; Stockmann, C.; Mazzone, M.. "Immunity, hypoxia, and metabolism–the ménage à trois of cancer: Implications for immunotherapy". Physiological Reviews 100 1 (2020): 1-102. http://www.scopus.com/inward/record.url?eid=2-s2.0-85073763573&partnerID=MN8TOARS.
    10.1152/physrev.00018.2019
  30. Baltazar, F.; Afonso, J.; Costa, M.; Granja, S.. "Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy". Frontiers in Oncology 10 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85082649332&partnerID=MN8TOARS.
    10.3389/fonc.2020.00231
  31. Ferreira, N.; Mesquita, I.; Baltazar, F.; Silvestre, R.; Granja, S.. "IL-17A and IL-17F orchestrate macrophages to promote lung cancer". Cellular Oncology (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85082933909&partnerID=MN8TOARS.
    10.1007/s13402-020-00510-y
  32. Choubey, Mayank; Ranjan, Ashutosh; Bora, Puran S.; Baltazar, Fátima; Krishna, Amitabh. "Direct actions of adiponectin on changes in reproductive, metabolic, and anti-oxidative enzymes status in the testis of adult mice". General and Comparative Endocrinology 279 (2019): 1-11. http://dx.doi.org/10.1016/j.ygcen.2018.06.002.
    10.1016/j.ygcen.2018.06.002
  33. Rodrigues, J.A.; Amorim, R.; Silva, M.F.; Baltazar, F.; Wolffenbuttel, R.F.; Correia, J.H.. "Photodynamic Therapy at Low-Light Fluence Rate: In vitro Assays on Colon Cancer Cells". IEEE Journal of Selected Topics in Quantum Electronics 25 1 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85059044628&partnerID=MN8TOARS.
    10.1109/JSTQE.2018.2889426
  34. Choubey, M.; Ranjan, A.; Bora, P.S.; Baltazar, F.; Martin, L.J.; Krishna, A.. "Role of adiponectin as a modulator of testicular function during aging in mice". Biochimica et Biophysica Acta - Molecular Basis of Disease 1865 2 (2019): 413-427. http://www.scopus.com/inward/record.url?eid=2-s2.0-85057436327&partnerID=MN8TOARS.
    10.1016/j.bbadis.2018.11.019
  35. Ferreira, D.; Silva, A.P.; Nobrega, F.L.; Martins, I.M.; Barbosa-Matos, C.; Granja, S.; Martins, S.F.; Baltazar, F.; Rodrigues, L.R.. "Rational Identification of a Colorectal Cancer Targeting Peptide through Phage Display". Scientific Reports 9 1 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85062606366&partnerID=MN8TOARS.
    10.1038/s41598-019-40562-1
  36. Afonso, J.; Pinto, T.; Simões-Sousa, S.; Schmitt, F.; Longatto-Filho, A.; Pinheiro, C.; Marques, H.; Baltazar, F.. "Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma – MCT1 as potential target in diffuse large B cell lymphoma". Cellular Oncology 42 3 (2019): 303-318. http://www.scopus.com/inward/record.url?eid=2-s2.0-85062011171&partnerID=MN8TOARS.
    10.1007/s13402-019-00426-2
  37. Pereira, D.S.M.; Cardoso, B.D.; Rodrigues, A.R.O.; Amorim, C.O.; Amaral, V.S.; Almeida, B.G.; Queiroz, M.-J.R.P.; et al. "Magnetoliposomes containing calcium ferrite nanoparticles for applications in breast cancer therapy". Pharmaceutics 11 9 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85074586220&partnerID=MN8TOARS.
    10.3390/pharmaceutics11090477
  38. Oliveira, C.; Granja, S.; Neves, N.M.; Reis, R.L.; Baltazar, F.; Silva, T.H.; Martins, A.. "Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo". Carbohydrate Polymers 223 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85068787985&partnerID=MN8TOARS.
    10.1016/j.carbpol.2019.115034
  39. Natália Vilaça; Juan Gallo; Rui Fernandes; Francisco Figueiredo; António M. Fonseca; Fátima Baltazar; Isabel C. Neves; et al. "Synthesis, characterization and in vitro validation of a magnetic zeolite nanocomposite with T2-MRI properties towards theranostic applications". Journal of Materials Chemistry B 7 21 (2019): 3351-3361. https://doi.org/10.1039/C9TB00078J.
    10.1039/C9TB00078J
  40. Pontes, Olívia; Costa, Marta Sílvia Freitas; Santos, Filipa; Marques, Maria Belém Sousa Sampaio; Dias, Tatiana Alexandra Freitas Perdigão; Ludovico, Paula; Baltazar, Fátima; Proença, M. Fernanda R. P.. "Exploitation of New Chalcones and 4H-chromenes as Agents for Cancer Treatment". European Journal of Medicinal Chemistry 157 (2018): 101-114. http://hdl.handle.net/1822/58102.
    Published • 10.1016/j.ejmech.2018.07.058
  41. Figueiredo, Pedro; Costa, Marta; Pontes, Olívia; Baltazar, Fátima; Proença, Fernanda. "Adenine Derivatives: Promising Candidates for Breast Cancer Treatment". European Journal of Organic Chemistry 2018 29 (2018): 3943-3956. http://dx.doi.org/10.1002/ejoc.201800629.
    10.1002/ejoc.201800629
  42. Gomes, Sara Daniela; Oliveira, Claudia Suellen; Azevedo-Silva, Joao; Casanova, Marta; Barreto, Judite; Pereira, Helena; Chaves, Susana; et al. "The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications.". Current Medicinal Chemistry 25 (2018): http://dx.doi.org/10.2174/0929867325666180530102050.
    10.2174/0929867325666180530102050
  43. Tavares-Valente, Diana; Granja, Sara; Baltazar, Fátima; Queirós, Odília. "Bioenergetic modulators hamper cancer cell viability and enhance response to chemotherapy". Journal of Cellular and Molecular Medicine 22 8 (2018): 3782-3794. http://dx.doi.org/10.1111/jcmm.13642.
    10.1111/jcmm.13642
  44. Silva, Eduardo C.A.; Cárcano, Flavio M.; Bonatelli, Murilo; Zaia, Maurício G.; Morais-Santos, Filipa; Baltazar, Fátima; Lopes, Luiz F.; Scapulatempo-Neto, Cristovam; Pinheiro, Céline. "The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors". Oncotarget 9 29 (2018): http://dx.doi.org/10.18632/oncotarget.24910.
    10.18632/oncotarget.24910
  45. Vilaça, Natália; Totovao, Ricardo; Prasetyanto, Eko Adi; Miranda-Gonçalves, Vera; Morais-Santos, Filipa; Fernandes, Rui; Figueiredo, Francisco; et al. "Internalization studies on zeolite nanoparticles using human cells". Journal of Materials Chemistry B 6 3 (2018): 469-476. http://dx.doi.org/10.1039/c7tb02534c.
    10.1039/c7tb02534c
  46. Vera Miranda-Gonçalves; Filipa Bezerra; Raquel Costa-Almeida; Marta Freitas-Cunha; Raquel Soares; Olga Martinho; Rui M. Reis; Céline Pinheiro; Fátima Baltazar. "Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk". Molecular Carcinogenesis 56 12 (2017): 2630-2642. https://doi.org/10.1002/mc.22707.
    10.1002/mc.22707
  47. Ferreira, Natália N.; M.B. Ferreira, Leonardo; Miranda-Gonçalves, Vera; Reis, Rui M.; Seraphim, Thiago V.; Borges, Júlio César; Baltazar, Fátima; Gremião, Maria Palmira D.. "Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy". European Journal of Pharmaceutics and Biopharmaceutics 119 (2017): 271-282. http://dx.doi.org/10.1016/j.ejpb.2017.06.028.
    10.1016/j.ejpb.2017.06.028
  48. Granja, Sara; Tavares-Valente, Diana; Queirós, Odília; Baltazar, Fátima. "Value of pH regulators in the diagnosis, prognosis and treatment of cancer". Seminars in Cancer Biology 43 (2017): 17-34. http://dx.doi.org/10.1016/j.semcancer.2016.12.003.
    10.1016/j.semcancer.2016.12.003
  49. Martinho, Olga; Silva-Oliveira, Renato; Cury, Fernanda P.; Barbosa, Ana Martins; Granja, Sara; Evangelista, Adriane Feijó; Marques, Fábio; et al. "HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors". Theranostics 7 3 (2017): 717-732. http://dx.doi.org/10.7150/thno.17154.
    10.7150/thno.17154
  50. Vilaça, N.; Machado, A.F.; Morais-Santos, F.; Amorim, R.; Patrícia Neto, A.; Logodin, E.; Pereira, M.F.R.; et al. "Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors". RSC Advances 7 22 (2017): 13104-13111. http://www.scopus.com/inward/record.url?eid=2-s2.0-85014224901&partnerID=MN8TOARS.
    10.1039/c7ra01028a
  51. Vieira de Castro, J.; Gomes, E.D.; Granja, S.; Anjo, S.I.; Baltazar, F.; Manadas, B.; Salgado, A.J.; Costa, B.M.. "Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology". Journal of Translational Medicine 15 1 (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85030718763&partnerID=MN8TOARS.
    10.1186/s12967-017-1303-8
  52. Pinheiro, C.; Granja, S.; Longatto-Filho, A.; Faria, A.M.; Fragoso, M.C.B.V.; Lovisolo, S.M.; Bonatelli, M.; et al. "GLUT1 expression in pediatric adrenocortical tumors: A promising candidate to predict clinical behavior". Oncotarget 8 38 (2017): 63835-63845. http://www.scopus.com/inward/record.url?eid=2-s2.0-85029795275&partnerID=MN8TOARS.
    10.18632/oncotarget.19135
  53. Miranda-Gonçalves, V.; Cardoso-Carneiro, D.; Valbom, I.; Cury, F.P.; Silva, V.A.; Granja, S.; Reis, R.M.; Baltazar, F.; Martinho, O.. "Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells". Oncotarget 8 61 (2017): 103657-103670. http://www.scopus.com/inward/record.url?eid=2-s2.0-85035349210&partnerID=MN8TOARS.
    10.18632/oncotarget.21761
  54. Rossi, Esther Diana; Bizzarro, Tommaso; Granja, Sara; Martini, Maurizio; Capodimonti, Sara; Luca, Emilia; Fadda, Guido; et al. "The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation". Endocrine 56 2 (2016): 379-387. http://dx.doi.org/10.1007/s12020-016-1044-0.
    10.1007/s12020-016-1044-0
  55. Cárcano, F. M.; Lengert, A. H.; Vidal, D. O.; Scapulatempo Neto, C.; Queiroz, L.; Marques, H.; Baltazar, F.; et al. "Absence of microsatellite instability andBRAF(V600E) mutation in testicular germ cell tumors". Andrology 4 5 (2016): 866-872. http://dx.doi.org/10.1111/andr.12200.
    10.1111/andr.12200
  56. Pinheiro, C.; Miranda-Gonçalves, V.; Longatto-Filho, A.; Vicente, A.L.S.A.; Berardinelli, G.N.; Scapulatempo-Neto, C.; Costa, R.F.A.; et al. "The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4". Cell Cycle 15 11 (2016): 1462-1470. http://www.scopus.com/inward/record.url?eid=2-s2.0-84969138646&partnerID=MN8TOARS.
    10.1080/15384101.2016.1175258
  57. Miranda-Gonçalves, V.; Granja, S.; Martinho, O.; Honavar, M.; Pojo, M.; Costa, B.M.; Pires, M.M.; et al. "Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas". Oncotarget 7 29 (2016): 46335-46353. http://www.scopus.com/inward/record.url?eid=2-s2.0-84979950555&partnerID=MN8TOARS.
    10.18632/oncotarget.10114
  58. Ferro, S.; Azevedo-Silva, J.; Casal, M.; Côrte-Real, M.; Baltazar, F.; Preto, A.. "Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications". Oncotarget 7 43 (2016): 70639-70653. http://www.scopus.com/inward/record.url?eid=2-s2.0-84994365911&partnerID=MN8TOARS.
    10.18632/oncotarget.12156
  59. Azevedo-Silva, J.; Queirós, O.; Baltazar, F.; Ulaszewski, S.; Goffeau, A.; Ko, Y.H.; Pedersen, P.L.; Preto, A.; Casal, M.. "The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside". Journal of Bioenergetics and Biomembranes 48 4 (2016): 349-362. http://www.scopus.com/inward/record.url?eid=2-s2.0-84979641440&partnerID=MN8TOARS.
    10.1007/s10863-016-9670-z
  60. Simões-Sousa, S.; Granja, S.; Pinheiro, C.; Fernandes, D.; Longatto-Filho, A.; Laus, A.C.; Alves, C.D.C.; et al. "Prognostic significance of monocarboxylate transporter expression in oral cavity tumors". Cell Cycle 15 14 (2016): 1865-1873. http://www.scopus.com/inward/record.url?eid=2-s2.0-84976299772&partnerID=MN8TOARS.
    10.1080/15384101.2016.1188239
  61. Martins, S.F.; Amorim, R.; Viana-Pereira, M.; Pinheiro, C.; Costa, R.F.A.; Silva, P.; Couto, C.; et al. "Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis". BMC Cancer 16 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84979211096&partnerID=MN8TOARS.
    10.1186/s12885-016-2566-9
  62. Afonso, J.; Santos, L.L.; Morais, A.; Amaro, T.; Longatto-Filho, A.; Baltazar, F.; Afonso J; et al. "Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness". Cell Cycle 15 3 (2016): 368-380. http://www.scopus.com/inward/record.url?eid=2-s2.0-84964887853&partnerID=MN8TOARS.
    10.1080/15384101.2015.1121329
  63. Pedro, Dalila F.¿N.; Ramos, Alice A.; Lima, Cristovao F.; Baltazar, Fatima; Pereira-Wilson, Cristina; Pedro DF; Ramos AA; et al. "Colon Cancer Chemoprevention by Sage Tea Drinking: Decreased DNA Damage and Cell Proliferation". Phytotherapy Research 30 2 (2015): 298-305. http://dx.doi.org/10.1002/ptr.5531.
    10.1002/ptr.5531
  64. Miranda-Gonçalves V; Reis RM; Baltazar F; Miranda-Gonçalves, V.; Reis, R.M.; Baltazar, F.. "Lactate transporters and pH regulation: potential therapeutic targets in glioblastomas.". Current Cancer Drug Targets 16 5 (2015): 388-399. http://europepmc.org/abstract/med/26694251.
    10.2174/1568009616666151222150543
  65. Cárcano FM; Vidal DO; van Helvoort Lengert A; Neto CS; Queiroz L; Marques H; Baltazar F; et al. "Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.". Tumor Biology 37 4 (2015): 4901-4907. http://europepmc.org/abstract/med/26526580.
    10.1007/s13277-015-4317-y
  66. Granja, Sara; Pinheiro, Celine; Reis, Rui; Martinho, Olga; Baltazar, Fatima; Granja, S.; Pinheiro, C.; et al. "Glucose addiction in cancer therapy: advances and drawbacks". Current Drug Metabolism 16 3 (2015): 221-242. http://dx.doi.org/10.2174/1389200216666150602145145.
    10.2174/1389200216666150602145145
  67. Amorim, Ricardo; Pinheiro, Céline; Miranda-Gonçalves, Vera; Pereira, Helena; Moyer, Mary P.; Preto, Ana; Baltazar, Fátima. "Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells". Cancer Letters 365 1 (2015): 68-78. http://dx.doi.org/10.1016/j.canlet.2015.05.015.
    10.1016/j.canlet.2015.05.015
  68. Morais-Santos F; Granja S; Miranda-Gonçalves V; Moreira AH; Queirós S; Vilaça JL; Schmitt FC; et al. "Targeting lactate transport suppresses in vivo breast tumour growth.". Oncotarget 6 22 (2015): 19177-19189. http://europepmc.org/abstract/med/26203664.
  69. Pertega-Gomes N; Felisbino S; Massie CE; Vizcaino JR; Coelho R; Sandi C; Simoes-Sousa S; et al. "A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.". (2015): http://europepmc.org/abstract/med/25875424.
    10.1002/path.4547
  70. Oliveira, C S F; Pereira, H; Alves, S; Castro, L; Baltazar, F; Chaves, S R; Preto, A; Côrte-Real, M. "Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria". Cell Death & Disease 6 6 (2015): e1788-e1788. http://dx.doi.org/10.1038/cddis.2015.157.
    10.1038/cddis.2015.157
  71. Valença, Isabel; Pértega-Gomes, Nelma; Vizcaino, José Rámon; Henrique, Rui M.; Lopes, Carlos; Baltazar, Fátima; Ribeiro, Daniela. "Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer". Journal of Cellular and Molecular Medicine 19 4 (2015): 723-733. http://dx.doi.org/10.1111/jcmm.12481.
    10.1111/jcmm.12481
  72. Afonso, J.; Freitas, R.; Lobo, F.; Morais, A.; Amaro, T.; Reis, R.; Baltazar, F.; et al. "Evolving hallmarks in urothelial bladder cancer: unveiling potential biomarkers". Acta Urológica Portuguesa 32 1 (2015): 1-11. http://dx.doi.org/10.1016/j.acup.2014.12.002.
    10.1016/j.acup.2014.12.002
  73. Silva-Carvalho, Ricardo; Baltazar, Fátima; Almeida-Aguiar, Cristina. "Propolis: A Complex Natural Product with a Plethora of Biological Activities That Can Be Explored for Drug Development". Evidence-Based Complementary and Alternative Medicine 2015 (2015): 1-29. http://dx.doi.org/10.1155/2015/206439.
    10.1155/2015/206439
  74. Afonso, JulietaP; Freitas, Rui; Lobo, Francisco; Morais, António; Oliveira, Jorge; Amaro, Teresina; Reis, RuiM; et al. "Urothelial bladder cancer progression: lessons learned from the bench". Journal of Cancer Metastasis and Treatment 1 2 (2015): 57. http://dx.doi.org/10.4103/2394-4722.157377.
    10.4103/2394-4722.157377
  75. Granja, S.; Marchiq, I.; Le Floch, R.; Moura, C.S.; Baltazar, F.; Pouysségur, J.. "Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status". Oncotarget 6 9 (2015): 6708-6721. http://www.scopus.com/inward/record.url?eid=2-s2.0-84927127315&partnerID=MN8TOARS.
  76. Pinheiro C; Garcia EA; Morais-Santos F; Moreira MA; Almeida FM; Jubé LF; Queiroz GS; et al. "Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas.". (2015): http://europepmc.org/abstract/med/26525902.
    10.1186/s12885-015-1842-4
  77. Martinho, Olga; Vilaca, Natalia; Castro, Paulo J. G.; Amorim, Ricardo; Fonseca, Antonio M.; Baltazar, Fatima; Reis, Rui M.; Neves, Isabel C.. "In vitro and in vivo studies of temozolomide loading in zeolite structures as drug delivery systems for glioblastoma". Rsc Advances 5 36 (2015): 28219-28227. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000351870500026&KeyUID=WOS:000351870500026.
    10.1039/c5ra03871e
  78. Vilaça, N.; Morais-Santos, F.; Machado, A.F.; Sirkecio¿lu, A.; Pereira, M.F.R.; Sardo, M.; Rocha, J.; et al. "Micro- and mesoporous structures as drug delivery carriers for salicylic acid". Journal of Physical Chemistry C 119 7 (2015): 3589-3595. http://www.scopus.com/inward/record.url?eid=2-s2.0-84923374916&partnerID=MN8TOARS.
    10.1021/jp5117849
  79. Azevedo-Silva, J.Ã.; Queirós, O.; Ribeiro, A.; Baltazar, F.; Young, K.H.; Pedersen, P.L.; Pretoand, A.; Casal, M.. "The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH". Biochemical Journal 467 2 (2015): 247-258. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930804928&partnerID=MN8TOARS.
    10.1042/BJ20140921
  80. Azevedo, M.-M.; Pinheiro, C.; Dias, A.C.P.; Pinto-Ribeiro, F.; Baltazar, F.. "Impact of an educational hands-on project on the antimicrobial, antitumor and anti-inflammatory properties of plants on portuguese students’ awareness, knowledge, and competences". International Journal of Environmental Research and Public Health 12 3 (2015): 2437-2453. http://www.scopus.com/inward/record.url?eid=2-s2.0-84927586441&partnerID=MN8TOARS.
    10.3390/ijerph120302437
  81. Vieira, F.Q.; Costa-Pinheiro, P.; Almeida-Rios, D.; Graça, I.; Monteiro-Reis, S.; Simões-Sousa, S.; Carneiro, I.; et al. "SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3". Oncotarget 6 15 (2015): 13644-13657. http://www.scopus.com/inward/record.url?eid=2-s2.0-84979900432&partnerID=MN8TOARS.
    10.18632/oncotarget.3767
  82. Pinheiro, C.; Granja, S.; Longatto-Filho, A.; Faria, A.M.; Fragoso, M.; Lovisolo, S.M.; Lerário, A.; et al. "Metabolic reprogramming: A new relevant pathway in adult adrenocortical tumors". Oncotarget 6 42 (2015): 44403-44421. http://www.scopus.com/inward/record.url?eid=2-s2.0-84953410803&partnerID=MN8TOARS.
    10.18632/oncotarget.5623
  83. Baltazar, Fátima; Pinheiro, Céline; Santos, Filipa Morais; Silva, J. Azevedo; Queirós, Odília; Preto, Ana; Casal, Margarida; et al. "Monocarboxylate Transporters as Targets and Mediators in Cancer Therapy Response". Histology and Histopathology 29 12 (2014): 1511-1524. http://hdl.handle.net/1822/32518.
    Published
  84. Silva-Carvalho, Ricardo; Miranda-Gonçalves, Vera; Ferreira, Ana Margarida; Cardoso, Susana M.; Sobral, Abílio J.F.N.; Almeida-Aguiar, Cristina; Baltazar, Fátima. "Antitumoural and antiangiogenic activity of Portuguese propolis in in vitro and in vivo models". Journal of Functional Foods 11 (2014): 160-171. http://dx.doi.org/10.1016/j.jff.2014.09.009.
    10.1016/j.jff.2014.09.009
  85. Pértega-Gomes, Nelma; Baltazar, Fátima. "Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?". International Journal of Molecular Sciences 15 10 (2014): 18333-18348. http://dx.doi.org/10.3390/ijms151018333.
    10.3390/ijms151018333
  86. Afonso, Julieta; Santos, Lúcio L.; Miranda-Gonçalves, Vera; Morais, António; Amaro, Teresina; Longatto-Filho, Adhemar; Baltazar, Fátima. "CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance". Molecular Carcinogenesis 54 11 (2014): 1451-1466. http://dx.doi.org/10.1002/mc.22222.
    10.1002/mc.22222
  87. Pinto, F.; Pertega-Gomes, N.; Pereira, M. S.; Vizcaino, J. R.; Monteiro, P.; Henrique, R. M.; Baltazar, F.; Andrade, R. P.; Reis, R. M.. "T-box Transcription Factor Brachyury Is Associated with Prostate Cancer Progression and Aggressiveness". Clinical Cancer Research 20 18 (2014): 4949-4961. http://dx.doi.org/10.1158/1078-0432.ccr-14-0421.
    10.1158/1078-0432.ccr-14-0421
  88. Azevedo, Maria Manuel; Pinheiro, Céline; Miranda, Isabel; Baltazar, Fátima. "How to decipher a microbial puzzle on microbial control : hands on". Online International Interdisciplinary Research Journal 4 (2014): http://hdl.handle.net/1822/29342.
  89. Alves, Venâncio A. "Characterization of monocarboxylate transporter activity in hepatocellular carcinoma". World Journal of Gastroenterology 20 33 (2014): 11780. http://dx.doi.org/10.3748/wjg.v20.i33.11780.
    10.3748/wjg.v20.i33.11780
  90. Granja, Sara; Marchiq, Ibtissam; Baltazar, Fatima; Pouyssegur, Jacques. "Gene disruption using zinc finger nuclease technology". Methods in molecular biology (Clifton, N.J.) 1165 (2014): 253-60.
    10.1007/978-1-4939-0856-1_17
  91. Sousa, B.; Ribeiro, A.S.; Nobre, A.R.; Lopes, N.; Martins, D.; Pinheiro, C.; Vieira, A.F.; et al. "The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype". BMC Cancer 14 1 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84908094892&partnerID=MN8TOARS.
    10.1186/1471-2407-14-734
  92. Pinheiro, C.; Garcia, E.A.; Morais-Santos, F.; Scapulatempo-Neto, C.; Mafra, A.; Steenbergen, R.D.M.; Boccardo, E.; et al. "Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix". BMC Cancer 14 1 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84908068548&partnerID=MN8TOARS.
    10.1186/1471-2407-14-751
  93. Pinheiro, Celine; Penna, Valter; Morais-Santos, Filipa; Abrahao-Machado, Lucas F.; Ribeiro, Guilherme; Curcelli, Emilio C.; Olivieri, Marcus V.; et al. "Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization". Journal of Translational Medicine 12 (2014):
    10.1186/1479-5876-12-118
  94. Pértega-Gomes, N.; Vizcaíno, J.R.; Attig, J.; Jurmeister, S.; Lopes, C.; Baltazar, F.. "A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer". BMC Cancer 14 1 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84901597401&partnerID=MN8TOARS.
    10.1186/1471-2407-14-352
  95. Vilaça, Natália; Amorim, Ricardo; Machado, Ana F.; Parpot, Pier; Pereira, Manuel F.R.; Sardo, Mariana; Rocha, João; et al. "Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma". Colloids and Surfaces B: Biointerfaces 112 (2013): 237-244. http://dx.doi.org/10.1016/j.colsurfb.2013.07.042.
    10.1016/j.colsurfb.2013.07.042
  96. Morais-Santos, Filipa; Miranda-Gonçalves, Vera; Pinheiro, Sílvia; Vieira, André F; Paredes, Joana; Schmitt, Fernando C; Baltazar, Fátima; et al. "Differential sensitivities to lactate transport inhibitors of breast cancer cell lines". Endocrine-Related Cancer 21 1 (2013): 27-38. http://dx.doi.org/10.1530/erc-13-0132.
    10.1530/erc-13-0132
  97. Valença, Isabel; Morais-Santos, Filipa; Miranda-Gonçalves, Vera; Ferreira, Ana Margarida; Almeida-Aguiar, Cristina; Baltazar, Fátima. "Portuguese propolis disturbs glycolytic metabolism of human colorectal cancer in vitro". BMC Complementary and Alternative Medicine 13 1 (2013): http://dx.doi.org/10.1186/1472-6882-13-184.
    10.1186/1472-6882-13-184
  98. Azevedo MM; Pinheiro C; Yaphe J; Baltazar F; Azevedo, M.M.; Pinheiro, C.; Yaphe, J.; Baltazar, F.. "Assessing the impact of a school intervention to promote students' knowledge and practices on correct antibiotic use.". International journal of environmental research and public health 10 7 (2013): 2920-2931. http://europepmc.org/abstract/med/23860183.
    10.3390/ijerph10072920
  99. Pértega-Gomes N; Vízcaíno JR; Miranda-Gonçalves V; Lopes C; Baltazar F. "Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs).". (2013): http://europepmc.org/abstract/PMC/PMC3624157.
  100. Amorim R; Martins S; Longatto-Filho A; Preto A; Baltazar F. "Exploiting monocarboxylate transporters as new molecular targets for colorectal carcinoma therapy.". (2013): http://europepmc.org/abstract/PMC/PMC3624101.
  101. Martins, Sandra; Reis, R. M.; Baltazar, Fátima; Longatto Filho, Adhemar. "A Hospital Based Cohort Study of Colorectal Cancer Cases Treated at Braga Hospital, Northern Portugal". Journal of Gastrointestinal & Digestive System 03 04 (2013): http://dx.doi.org/10.4172/2161-069x.1000146.
    10.4172/2161-069x.1000146
  102. Granja, Sara; Morais-Santos, Filipa; Miranda-Gonçalves, Vera; Viana-Ferreira, Manuel; Nogueira, Rosete; Nogueira-Silva, Cristina; Correia-Pinto, Jorge; Baltazar, Fátima. "The Monocarboxylate Transporter Inhibitor a-Cyano-4-Hydroxycinnamic Acid Disrupts Rat Lung Branching". Cellular Physiology and Biochemistry 32 6 (2013): 1845-1856. http://dx.doi.org/10.1159/000356617.
    10.1159/000356617
  103. Morais-Santos, F.; Pinheiro, C.; Vieira, A.; Schmitt, F.; Paredes, J.; Baltazar, F.. "Contribution of Monocarboxylate Transporters to the Aggressive Phenotype of Breast Cancer". Annals of Oncology 24 (2013): i30-i30. http://www.scopus.com/inward/record.url?eid=2-s2.0-85081570082&partnerID=MN8TOARS.
    10.1093/annonc/mdt047.8
  104. Martins, D.; Beça, F.F.; Sousa, B.; Baltazar, F.; Paredes, J.; Schmitt, F.. "Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma Key events in the progression from an in situ to an invasive breast carcinoma". Cell Cycle 12 16 (2013): 2684-2690. http://www.scopus.com/inward/record.url?eid=2-s2.0-84883237456&partnerID=MN8TOARS.
    10.4161/cc.25794
  105. Tavares-Valente, D.; Baltazar, F.; Moreira, R.; Queirós, O.. "Cancer cell bioenergetics and pH regulation influence breast cancer cell resistance to paclitaxel and doxorubicin". Journal of Bioenergetics and Biomembranes 45 5 (2013): 467-475. http://www.scopus.com/inward/record.url?eid=2-s2.0-84885635871&partnerID=MN8TOARS.
    10.1007/s10863-013-9519-7
  106. Miranda-Gonçalves, Vera; Honavar, Mrinalini; Pinheiro, Céline; Martinho, Olga; Pires, Manuel M.; Pinheiro, Célia; Cordeiro, Michelle; et al. "Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets". Neuro-Oncology 15 2 (2012): 172-188. http://dx.doi.org/10.1093/neuonc/nos298.
    10.1093/neuonc/nos298
  107. Pértega-Gomes, Nelma; Vizcaíno, José R.; Gouveia, Carlos; Jerónimo, Carmen; Henrique, Rui M.; Lopes, Carlos; Baltazar, Fátima. "Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer". The Prostate 73 7 (2012): 763-769. http://dx.doi.org/10.1002/pros.22620.
    10.1002/pros.22620
  108. Pinheiro, Céline; Longatto-Filho, Adhemar; Soares, Tony R.; Pereira, Helena; Bedrossian, Carlos; Michael, Claire; Schmitt, Fernando C.; Baltazar, Fátima. "CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma". Diagnostic Cytopathology 40 6 (2012): 478-483. http://dx.doi.org/10.1002/dc.22821.
    10.1002/dc.22821
  109. Pinheiro, C.; Longatto-Filho, A.; Nogueira, R.; Schmitt, F.; Baltazar, F.. "Lactate-Induced IL-8 Pathway in Endothelial Cells--Letter". Cancer Research 72 7 (2012): 1901-1902. http://dx.doi.org/10.1158/0008-5472.can-11-1540.
    10.1158/0008-5472.can-11-1540
  110. Queirós, Odília; Preto, Ana; Pacheco, António; Pinheiro, Céline; Azevedo-Silva, João; Moreira, Roxana; Pedro, Madalena; et al. "Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate". Journal of Bioenergetics and Biomembranes 44 1 (2012): 141-153. http://dx.doi.org/10.1007/s10863-012-9418-3.
    10.1007/s10863-012-9418-3
  111. Pinheiro C; Longatto-Filho A; Azevedo-Silva J; Casal M; Schmitt FC; Baltazar F. "Role of monocarboxylate transporters in human cancers: state of the art.". (2012): http://europepmc.org/abstract/med/22407107.
    10.1007/s10863-012-9428-1
  112. De Oliveira, A.T.T.; Pinheiro, C.; Longatto-Filho, A.; Brito, M.J.; Martinho, O.; Matos, D.; Carvalho, A.L.; et al. "Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)". Journal of Bioenergetics and Biomembranes 44 1 (2012): 171-178. http://www.scopus.com/inward/record.url?eid=2-s2.0-84858703378&partnerID=MN8TOARS.
    10.1007/s10863-012-9408-5
  113. Amorim, R.; Vilaça, N.; Martinho, O.; Reis, R.M.; Sardo, M.; Rocha, J.; Fonseca, A.M.; Baltazar, F.; Neves, I.C.. "Zeolite structures loading with an anticancer compound as drug delivery systems". Journal of Physical Chemistry C 116 48 (2012): 25642-25650. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870783596&partnerID=MN8TOARS.
    10.1021/jp3093868
  114. Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; et al. "GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.". Histology and Histopathology 26 10 (2011): 1279-1286. http://europepmc.org/abstract/med/21870331.
    Published
  115. Afonso, J.; Longatto-Filho, A.; Baltazar, F.; Sousa, N.; Costa, F.E.; Morais, A.; Amaro, T.; Lopes, C.; Santos, L.L.. "CD147 overexpression allows an accurate discrimination of bladder cancer patients’ prognosis". European Journal of Surgical Oncology (EJSO) 37 9 (2011): 811-817. http://dx.doi.org/10.1016/j.ejso.2011.06.006.
    10.1016/j.ejso.2011.06.006
  116. Vilaça, Natália; Amorim, Ricardo; Martinho, Olga; Reis, Rui M.; Baltazar, Fátima; Fonseca, António M.; Neves, Isabel C.. "Encapsulation of a-cyano-4-hydroxycinnamic acid into a NaY zeolite". Journal of Materials Science 46 23 (2011): 7511-7516. http://dx.doi.org/10.1007/s10853-011-5722-2.
    10.1007/s10853-011-5722-2
  117. Martins, Sandra F; Reis, Rui M; Rodrigues, Antonio Mesquita; Baltazar, Fátima; Filho, Adhemar Longatto; Martins SF; Reis RM; et al. "Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies". World Journal of Clinical Oncology 2 6 (2011): 272. http://dx.doi.org/10.5306/wjco.v2.i6.272.
    10.5306/wjco.v2.i6.272
  118. Pértega-Gomes, N.; Vizcaíno, J.R.; Miranda-Gonçalves, V.; Pinheiro, C.; Silva, J.; Pereira, H.; Monteiro, P.; et al. "Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.". BMC cancer 11 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-84856609812&partnerID=MN8TOARS.
    10.1186/1471-2407-11-312
  119. Pinheiro C; Albergaria A; Paredes J; Sousa B; Dufloth R; Vieira D; Schmitt F; Baltazar F. "Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma.". (2010): http://europepmc.org/abstract/med/20636790.
    10.1111/j.1365-2559.2010.03560.x
  120. Lima-Rodrigues, Manuel; Lamas, Nuno; Valle-Fernandes, Ana; Cruz, Andrea; Vieira, Artur; Oliveira, Pedro; Pedrosa, Jorge; et al. "The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment". Inflammation Research 59 9 (2010): 743-753. http://dx.doi.org/10.1007/s00011-010-0185-5.
    10.1007/s00011-010-0185-5
  121. Pedro DF; Ramos AA; Lima CF; Baltazar F; Pereira-Wilson C. "Modulation of DNA damage prevention and signaling pathways in diet induced colon cancer prevention.". (2010): http://europepmc.org/abstract/PMC/PMC3255057.
  122. Pinheiro, Céline; Reis, Rui M.; Ricardo, Sara; Longatto-Filho, Adhemar; Schmitt, Fernando; Baltazar, Fátima. "Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44". Journal of Biomedicine and Biotechnology 2010 (2010): 1-7. http://dx.doi.org/10.1155/2010/427694.
    10.1155/2010/427694
  123. Azevedo, Maria Manuel; Pinheiro, Céline; Yaphe, John; Baltazar, Fátima. "Portuguese students' knowledge of antibiotics: a cross-sectional study of secondary school and university students in Braga". BMC Public Health 9 1 (2009): http://dx.doi.org/10.1186/1471-2458-9-359.
    10.1186/1471-2458-9-359
  124. Pertega, Gomes N.; Ramon, Vizcaino J.; Pinheiro, C.; Baltazar, F.. "Monocarboxylate transporters 2 and 4 are upregulated in prostate carcinoma". Virchows Archiv 455 (2009): 233-233. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000268307700628&KeyUID=WOS:000268307700628.
  125. Pinheiro, Celine; Longatto-Filho, Adhemar; Miranda Pereira, Sonia Maria; Etlinger, Daniela; Moreira, Marise A. R.; Jube, Luiz Fernando; Queiroz, Geraldo Silva; et al. "Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma". Disease Markers 26 3 (2009): 97-103. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000268420400001&KeyUID=WOS:000268420400001.
    Published • 10.3233/dma-2009-0596
  126. Longatto-Filho, Adhemar; Gomes Malheiro, Luis Filipe; Milanezi, Fernanda; Pinheiro, Celine; Baltazar, Fatima; Schmitt, Fernando C.; Montironi, Rodolfo; et al. "Lymphatic Vessel Density in the Normal-Looking Columnar Epithelium Adjacent to and Distant from Prostatic Intraepithelial Neoplasia and Prostate Cancer Assessed in Whole-Mount Sections". Analytical and Quantitative Cytology and Histology 31 5 (2009): 269-275. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000207989500004&KeyUID=WOS:000207989500004.
  127. Pinheiro, C.; Longatto-Filho, A.; Simões, K.; Jacob, C.E.; Bresciani, C.J.C.; Zilberstein, B.; Cecconello, I.; et al. "The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer". European Journal of Cancer 45 13 (2009): 2418-2424. http://www.scopus.com/inward/record.url?eid=2-s2.0-68749120776&partnerID=MN8TOARS.
    10.1016/j.ejca.2009.06.018
  128. Longatto-Filho, A.; Pinheiro, C.; Martinho, O.; Moreira, M.A.R.; Ribeiro, L.F.J.; Queiroz, G.S.; Schmitt, F.C.; Baltazar, F.; Reis, R.M.. "Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma". BMC Cancer 9 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-67651093726&partnerID=MN8TOARS.
    10.1186/1471-2407-9-212
  129. Buijs, Manon; Vossen, Josephina A.; Geschwind, Jean-Francois H.; Ishimori, Takayoshi; Engles, James M.; Acha-Ngwodo, Obele; Wahl, Richard L.; Vali, Mustafa. "Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer". Investigational New Drugs 27 2 (2008): 120-123. http://dx.doi.org/10.1007/s10637-008-9145-0.
    10.1007/s10637-008-9145-0
  130. Macedo FY; Baltazar F; Mourão LC; Almeida PR; Mota JM; Schmitt FC; Ribeiro RA. "Induction of COX-2 expression by acrolein in the rat model of hemorrhagic cystitis.". (2008): http://europepmc.org/abstract/med/18234483.
    10.1016/j.etp.2007.10.010
  131. Pinheiro C; Longatto-Filho A; Scapulatempo C; Ferreira L; Martins S; Pellerin L; Rodrigues M; et al. "Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.". International Journal of Gynecological Pathology 27 4 (2008): 568-574. http://europepmc.org/abstract/med/18188595.
    10.1007/s00428-007-0558-5
  132. Lima-Rodrigues, Manuel; Valle-Fernandes, Ana; Lamas, Nuno; Cruz, Andrea; Baltazar, Fátima; Milanezi, Fernanda; Nunes, Rui; et al. "A New Model of Laryngitis: Neuropeptide, Cyclooxygenase, and Cytokine Profile". The Laryngoscope 118 1 (2008): 78-86. http://dx.doi.org/10.1097/mlg.0b013e3181492400.
    10.1097/mlg.0b013e3181492400
  133. Scapulatempo, C.; Longatto Filho, A.; Simoes, K.; Pinheiro, C.; Schmitt, F.; Baltazar, F.; Alves, V.. "Apoptosis detected by cleaved cytokeratin 18 (M30) immunohistochemistry in colorectal cancer is related to acidic tumoral microenviroment". Histopathology 53 (2008): 159-160. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000259524800368&KeyUID=WOS:000259524800368.
  134. Macedo, F.Y.B.; Baltazar, F.; Almeida, P.R.C.; Távora, F.; Ferreira, F.V.; Schmitt, F.C.; Brito, G.A.C.; Ribeiro, R.A.. "Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats". Journal of Cancer Research and Clinical Oncology 134 1 (2008): 19-27. http://www.scopus.com/inward/record.url?eid=2-s2.0-35948968829&partnerID=MN8TOARS.
    10.1007/s00432-007-0237-6
  135. Longatto-Filho, A.; Pinheiro, C.; Ferreira, L.; Scapulatempo, C.; Alves, V.A.F.; Baltazar, F.; Schmitt, F.. "Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers". Virchows Archiv 452 2 (2008): 133-138. http://www.scopus.com/inward/record.url?eid=2-s2.0-39149084004&partnerID=MN8TOARS.
    10.1007/s00428-007-0550-0
  136. Pinheiro, Celine; Longatto-Filho, Adhemar; Simbes, Kleber; Ferreira, Luisa; Alves, Venancio A. F.; Schmitt, Fernando; Baltazar, Fatima. "Monocarboxylate transporter expression correlates with CD147 and HIF-1 alpha in gastric cancermonocarboxylate transporter expression correlates with CD147 and HIF-1 alpha in gastric cancer". Virchows Archiv 452 (2008): S202-S203. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000256192600473&KeyUID=WOS:000256192600473.
  137. Simoes, K.; Longatto Filho, A.; Pinheiro, C.; Schmitt, F.; Ressio, R. Albergaria; Baltazar, F.; Alves, V.. "Increased apoptosis in gastric carcinogenesis progression can be influenced by mechanisms involved in tumoral microenviroment pH control". Histopathology 53 (2008): 162-163. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000259524800374&KeyUID=WOS:000259524800374.
  138. Pinheiro, C.; Longatto-Filho, A.; Pereira, S. M. M.; Etlinger, D.; Moreira, M.; Jube, L.; Schmitt, F.; Baltazar, F.. "CD147 expression correlates with monocarboxylate transporters 1 and 4 in cervical carcinoma". Ejc Supplements 6 12 (2008): 118-119. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000261221200377&KeyUID=WOS:000261221200377.
    10.1016/s1359-6349(08)72312-7
  139. Filho AL; Baltazar F; Bedrossian C; Michael C; Schmitt FC. "Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.". (2007): http://europepmc.org/abstract/med/18008346.
    10.1002/dc.20767
  140. Longatto Filho A; Costa SM; Milanezi F; Montruccoli D; Montruccoli GC; Baltazar F; Schmitt FC; et al. "Immunohistochemical expression of VEGF-A and its ligands in non-neoplastic lesions of the breast sampling-assisted by dynamic angiothermography.". Oncology Reports 18 5 (2007): 1201-1206. http://europepmc.org/abstract/med/17914573.
  141. Longatto-Filho A; Pinheiro C; Pereira SM; Etlinger D; Moreira MA; Jubé LF; Queiroz GS; Baltazar F; Schmitt FC. "Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix.". (2007): http://europepmc.org/abstract/med/17604828.
    10.1016/j.ygyno.2007.05.029
  142. Pinheiro, Celine; Longatto-Filho, Adhemar; Ferreira, Luisa; Scapulatempo, Cristovam; Af Alves, Venancio; Pellerin, Luc; Schmitt, Fernando; Baltazar, Fatima. "Altered expression of monocarboxylate transporters 1, 2 and 4 in colorectal carcinomas". Virchows Archiv 451 2 (2007): 325-325. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000249454600644&KeyUID=WOS:000249454600644.
  143. Baltazar, F.; Filho, A.L.; Pinheiro, C.; Moreira, M.A.R.; Queiroz, G.S.; Oton, G.J.B.; Júnior, A.F.; Ribeiro, L.F.J.; Schmitt, F.C.. "Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas". International Journal of Gynecological Pathology 26 3 (2007): 235-241. http://www.scopus.com/inward/record.url?eid=2-s2.0-34250870226&partnerID=MN8TOARS.
    10.1097/pgp.0b013e31802f1996
  144. Baltazar, Fátima; Cássio, Fernanda; Leão, Cecília. "Functional Purification of the Monocarboxylate Transporter of the Yeast Candida utilis". Biotechnology Letters 28 16 (2006): 1221-1226. http://dx.doi.org/10.1007/s10529-006-9088-5.
    10.1007/s10529-006-9088-5
  145. Reis Filho, J. S.; Pinheiro, C.; Lambros, M. B. K.; Milanezi, F.; Carvalho, S.; Savage, K.; Simpson, P. T.; et al. "EGFR amplification and lack of activating mutations in metaplastic breast carcinomas". Journal of Pathology 210 (2006): 59-59. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000240624500235&KeyUID=WOS:000240624500235.
  146. Reis, Jorge Sergio Filho; Pinheiro, Celine; Lambros, Maryou B. K.; Milanezi, Fernanda; Carvalho, Silvia; T Simpson, Pete; Jones, Chris; et al. "Recurrent EGFR amplification and lack of activating mutations in metaplastic breast carcinomas". Modern Pathology 19 (2006): 22-22. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000239999400087&KeyUID=WOS:000239999400087.
  147. Soares-Silva, I.; Schuller, D.; Andrade, R.P.; Baltazar, F.; Cássio, F.; Casal, M.. "Functional expression of the lactate permease Jen1p of Saccharomyces cerevisiae in Pichia pastoris". Biochemical Journal 376 3 (2003): 781-787. http://www.scopus.com/inward/record.url?eid=2-s2.0-0347986613&partnerID=MN8TOARS.
    10.1042/BJ20031180
  148. Gerós, H.; Baltazar, F.; Cássio, F.; Leão, C.; Geros, H.; Cassio, F.; Leao, C.. "L-[U-14C]Lactate binding to a 43 kDa protein in plasma membranes of Candida utilis". Microbiology 146 3 (2000): 695-699. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034057568&partnerID=MN8TOARS.
    10.1099/00221287-146-3-695
  149. Baltazar MF; Dickinson FM; Ratledge C; Baltazar, M. F.; Dickinson, F. M.; Ratledge, C.; Baltazar, M.F.; Dickinson, F.M.. "Oxidation of medium-chain acyl-CoA esters by extracts of Aspergillus niger: enzymology and characterization of intermediates by HPLC.". Microbiology-Uk 145 1 (1999): 271-278. http://europepmc.org/abstract/med/10206707.

Intellectual property

Patent
  1. Baltazar, F; Marta Costa; M. Fernanda Proença; Isabel Veiga; Carla Calçada; Pedro Ferreira. 2020. "ANTIMALARIAL AGENT, METHODS AND USES THEREOF". Portugal.
    Pending
  2. Baltazar, F; Marta Costa; M. Fernanda Proença; Patrícia Maciel; Olívia Pontes. 2020. "CHROMENE-BASED COMPOUNDS, METHODS AND USES THEREOF". Portugal.
    Pending
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2023/04/28 Monocarboxylate transporters (MCTs) as key players in the metabolic symbiosis between cancer cells and macrophages CCC-TRIO 2023, Translational Oncology & Immuno-Oncology
Medical University of Vienna (Vienna, Austria)
2023/04/14 Monocarboxylate transporters (MCTs) as targets and mediators for cancer therapy SciMINARS
University of Algarve (Faro, Portugal)
2023/03/28 Monocarboxylate transporters (MCTs) and their clinical significance in cancer EMBO lecture
Amity University (New Delhi, India)
2023/02/04 Nanoparticles and The Recent Scientific Advances In Cancer Diagnosis And Treatment XIV BeInMed
Universidade da Beira Interior (Covilhã, Portugal)
2022/09/29 “Targeting lactate transport as a therapeutic approach in glioblastoma” 6th Cancer World Congress “Personalized Cancer Diagnosis and Therapy”
Cancer World Congress (Lisbon, Portugal)
2022/05/10 Os transportadores de ácido láctico como alvos terapêuticos no cancro International festival of science communication "Pint of Science"
(Guimarães, Portugal)
2022/04/01 “Cancer Metabolism: glucose metabolism as target for cancer therapy” Oporto Biomedical Summit - 2nd Edition
(Porto, Portugal)
2021/11/23 Targeting lactate transport as a therapeutic approach in cancer 33rd AICC ANNUAL CONFERENCE: INTERNATIONAL MEETING ON CANCER METABOLISM
ASSOCIAZIONE ITALIANA DI CULTURE CELLULARI (AICC) (Turin, Italy)
2021/03/03 Role of Lactate Transporters (MCTs) in Cancer and Exploitation as Therapeutic Targets. CEDOC meetings
University of Lisbon (Lisbon, Portugal)
2020/04/23 Altered metabolism in cancer. Advanced course on oncobiology 3rd Ed., CESPU, Instituto Universitário de Ciências da Saúde
Instituto Universitário de Ciências da Saúde (Portugal)
2019/12/20 Altered metabolism as hallmark of cancer: role of lactate transporters. CIBB meeting
(Coimbra, Portugal)
2019/12/13 New chromene derivatives: unravelling the molecular mechanisms for breast cancer treatment. 13th Biological and Medicinal Chemistry Postgraduate Symposium
(Cambridge , United Kingdom)
2019/07/01 Expression of lactate transporters (MCTS) in human cancers and exploitation as therapeutic targets. INTERNATIONAL PROTEOMICS & METABOLOMICS CONFERENCE AND ADVANCED SCHOOL
(Verona, Italy)
2018/11/29 Lactate Transporters and pH Regulation: potential Targets in Cancer Therapy Course in Cancer Metabolism
TRANSMIT consortium (Bertinoro, Italy)
2018/10/28 Monocarboxylate transporters (MCTs) as targets for cancer therapy International workshop NO-CANCER 2018, Understanding Cancer Cell Biology to improve Diagnosis and Therapy
(Novara, Italy)
2018/10 Monocarboxylate transporters (MCTs) as markers of metabolic adaptations in malignant tumours 5th Annual Meeting of the International Society of Cancer Metabolism (ISCaM)
(Bratislava, Slovakia)
2018/09/28 Portuguese Propolis: a Source of Valuable Bioactivities Second Propolis Conference - Propolis in Human and Bee Health
(Sofia, Bulgaria)
2018/07/17 Role of lactate in cancer: targeting monocarboxylate transporters XI Ciclo de Seminários CICS-UBI
(Covilhã, Portugal)
2018/04/30 Altered metabolism in cancer Advanced course on oncobiology 3rd Ed., CESPU
(Gandra, Portugal)
2018/04/30 Altered metabolism in cancer Advanced course on oncobiology 3rd Ed., CESPU, Instituto Universitário de Ciências da Saúde
(Famalicão, Portugal)
2017/10 Role of ECM collagen I levels in regulating PDAC parenchymal cell (CPC) and cancer stem cell (CSC) metabolic plasticity 4th ISCaM 2017
(Bertinoro, Italy)
2017/06/22 Lactate transporters as therapeutic targets in cancer therapy FEBS Advanced Lecture Course on Oncometabolism
(Figueira da Foz, Portugal)
2017/05/18 Therapeutic options in cancer Cancer therapy: from basic research to clinic. Departamento de Biologia, Universidade do Minho
(Braga, Portugal)
2017/05/02 Inibição dos transportadores de monocarboxilatos (MCTs) da terapêutica do cancro Conferências em Oncobiologia 2017. Faculdade de Farmácia, Universidade do Porto
(Porto, Portugal)
2017/04/28 Altered metabolism in cancer Advanced course on oncobiology 2nd Ed., CESPU, Instituto Universitário de Ciências da Saúde
(Famalicão, Portugal)
2017/04/21 Tumor metabolism as therapeutic target in cancer Encontros da Primavera 2017
(Évora, Portugal)
2016/12/09 Monocarboxylate transporter 1 (MCT1) in glioblastoma: prognostic value and exploitation as therapeutic target Congresso Nacional da Sociedade Portuguesa de Bioquímica
2016/10/07 Nutrient supply and cancer cell metabolism: can we modulate cancer fueling? Meeting "Nutrients Beyond Nutrition 5 -Nutrients before, during and after cancer: from primary prevention to therapy and secondary prevention"
(Genova, Italy)
2016/05/06 Cell Metabolism as Target for Cancer Therapy: Targeting Lactate Metabolism and Transport “ONCOBIOLOGY”, C.B.A.S PhD Program, Advanced Course, CESPU
(Famalicão, Portugal)
2016/04 The clinicopathological significance of monocarboxylate transporters (MCTs) in germ cell tumors
(Barretos, Brazil)
2015/12/11 Dicas na redação dos artigos científicos e estratégias de publicação Seminários em Oncologia, do Curso de Pós-Graduação Stricto Sensu em Oncologia do Hospital de Câncer de Barretos
(Barretos, Brazil)
2015/11/05 Cancer Metabolism: role of lactate transporters
(São Paulo, Brazil)
2015/10/20 Os transportadores de lactato (MCTs) como alvos terapêuticos no cancer Journal Club do Centro de Pesquisa em Oncologia Molecular do Hospital de Câncer de Barretos
(Barretos, Brazil)
2015/09 MCT1 plasma membrane expression as a mediator of cellular aggressiveness at hypoxic regions in glioblastomas 2nd ISCaM meeting - Metabolism and Microenvironment in cancer plasticity
(Venice, Italy)
2014/09 Energetic metabolism as target in cancer therapy IV Simpósio Internacional de Oncologia Translacional
(São Paulo, Brazil)
2014/04/29 O metabolismo energético como alvo terapêutico no cancro V Jornadas de Bioquímica
(Braga, Portugal)
2013/10 Significance of monocarboxylate transporter (MCT) expression in human tumors International Society for Proton Dynamics in Cancer
(Munich, Germany)
2013/09 Metabolic Targets in Cancer The 3rd Global Cancer Genomics Consortium Symposium
(Lisboa, Portugal)
2013/07 The role of monocarboxylate transporters in cancer microenvironment IUPS
(Birmingham, United Kingdom)
2013/04/29 Portuguese Propolis is a Source of Important Bioactivities Workshop Produtos Naturais
(Coimbra, Portugal)
2012/04 Lactate transport as a novel target for cancer therapy XXI Porto cancer meeting
(Porto, Portugal)
2011/09 Expression of Monocarboxylate transporters in human Cancers International Society for Proton Dynamics in Cancer
(Nice, France)
2011/09 Portuguese Propolis is a source of important Bioactivities APIMONDIA 2011 – 42nd International Apicultural Congress
(Buenos Aires, Argentina)
2011 Tracing the metabolic profile of prostate cancer development 23rd European Congress of Pathology
(Helsinki, Finland)
2010/05 Em busca das bioactividades escondidas 1ª Jornadas de Bioquímica
(Braga, Portugal)
2008/04 M. Laringite Neurogénica: prova terapêutica com o inibidor selectivo da COX-2 Etoricoxibe JOCEM
(Lisboa, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2022/02 - 2026/01 Lipid nanocarriers containing magnetic/gold nanoparticles coated with dendritic mesoporous silica for application in SCC skin cancer therapy
Co-supervisor
 Materials Engineering (PhD)
Universidade do Minho, Portugal
2021/10 - 2025/09 Chemodynamic therapy by Fenton-type reactions for cancer therapy using metal ion-zeolite nanomaterials
Co-supervisor
 Applied Chemistry (PhD)
Universidade do Minho, Portugal
2021/01 - 2024/12 Deciphering the role of the serine protease inhibitor SPINT2 managing melanoma tumorigenesis and therapeutic response
Co-supervisor
 Health Sciences (PhD)
Universidade do Minho, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2020/10 - 2024/09 Co-targeting of cancer glycolytic metabolism and angiogenesis through polymeric nanoparticles for glioblastoma therapeutics
Co-supervisor
 Biological Sciences Applied to Health (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2020 - 2024 Role of monocarboxylate transporters in the resistance phenotype of acute leukemia: therapeutic implications
Supervisor
 Health Sciences (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2020 - 2024 CD147 in cancer immunosurveillance: new tool for T-cell based immunotherapy
Co-supervisor
 Health Sciences (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2018/09 - 2023/10 Unveiling the role of diet microbioma-derived short chain fatty acids in prevention and therapy of colorectal cancer using “colon-on-a-chip” model
Co-supervisor
 Biology (PhD)
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2021/10 - 2022/10 Assessing the in vitro antimicrobial and antitumor properties of Portuguese propolis
Co-supervisor
 Applied Biochemistry (Master)
Universidade do Minho, Portugal

Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2021/10 - 2022/10 Monocarboxylate transporters (MCTs): key players in the metabolic symbiosis between tumour cells and macrophages
Co-supervisor
 Health Sciences
Universidade do Minho, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2020/09 - 2022/03 Assessing the in vitro antimicrobial and antitumor properties of Portuguese propolis
Co-supervisor
 Molecular Genetics (Master)
Universidade do Minho, Portugal

Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2020 - 2022/02 Treatment of triple-negative breast cancer through externally triggered target-less drug carriers
Supervisor
 Health Sciences (Master)
Universidade do Minho, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2019 - 2022 Targeting oncogenic miRNAs in Triple Negative Breast Cancer using CRISPR/cas9-based approach
Co-supervisor
 Bioengineering (PhD)
Universidade do Minho Centro de Engenharia Biológica, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2018 - 2022 Innovative approach for targeted cancer therapy based on dual-loaded silica nanostructures as new Drug Delivery Systems
Supervisor
 Ciências da Saúde (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Universidade do Minho Departamento de Química, Portugal
2017 - 2021 Metabolic modeling based algorithms for drug discovery in cancer
Co-supervisor
 Biomedical Engineering (PhD)
Universidade do Minho Escola de Engenharia, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2017 - 2021 Synthesis, characterization and optimization of novel targeted inhibitors for renal cell carcinoma therapy
Supervisor
 Ciências da Saúde (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2016 - 2020 Nanostructured Multifunctional Systems fro Drug Release Through the Nasal Route Applied on Glioblastomas Treatment
Co-supervisor
 in Pharmaceutical Sciences (PhD)
Universidade Estadual Paulista Júlio de Mesquita Filho, Brazil

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2014 - 2020 Synthesis and anticancer evaluation of swainsonine analogues and derivatives obtained from D-erythrose
Co-supervisor
 Ciências (PhD)
Universidade do Minho Centro de Química, Portugal
2014 - 2020 Tackling metabolism in cancer cells: implications for gastrointestinal cancer therapy
Supervisor
 Ciências da Saúde (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2018 - 2019 Avaliação da atividade antimicrobiana e antitumoral de antibióticos encapsulados em estruturas zeolíticas
Co-supervisor
 Técnicas de Caracterização e Análise Química (Master)
Universidade do Minho Departamento de Química, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2017 - 2018 Uncovering the role of acetate in the crosstalk between monocarboxylate transporters and oncogene signalling pathways in colorectal cancer
Co-supervisor
 Molecular Genetics (Master)
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2017 - 2018 Targeting cancer cell metabolism using targeted drug delivery systems
Co-supervisor
 Health Sciences (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2017 - 2018 Characterization of glycolytic metabolism of oesophageal carcinomas and evaluation of its potential as therapeutic target
Co-supervisor
 Health Sciences (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2014 - 2018 Zeolite structures as cancer-targeted drug delivery carriers
Co-supervisor
 Ciências (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Universidade do Minho Centro de Química, Portugal
2014 - 2018 The influence of cancer cell metabolism and microenvironment on tumor progression and drug resistance”, PhD program in Health Sciences, School of Medicine
Supervisor
 Ciências da Saúde (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2013 - 2017 Monocarboxylate transporters (MCTs) in breast cancer aggressiveness: therapeutic targeting and regulatory mechanisms
Supervisor
 Ciências da Saúde (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2012 - 2016 Unravel the mechanisms of acetate induced apoptosis in colorectal carcinoma
Co-supervisor
 Patologia e Genética Molecular (PhD)
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2012 - 2016 Targeting lactate transport in gliomas: regulation and involvement in therapy resistance
Supervisor
 Ciências da Saúde (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2010 - 2014 Role of monocarboxylate transporters in prostate cancer
Supervisor
 Patologia e Genética Molecular (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2009 - 2014 P-cadherin overexpression in breast carcinomas: role in cancer cell survival and invasion in response to tumour hypoxic conditions
Co-supervisor
 Patologia e Genética Molecular (PhD)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2012 - 2013 Monocarboxylate transporters as angiogenic mediators: role on endothelial-tumor cell crosstalk
Supervisor
 Health Sciences (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2012 - 2013 Characterization of the Antitumoral Activity of Portuguese Propolis
Supervisor
 Health Sciences (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
2012 - 2013 Desenvolvimento de sistemas de libertação de fármacos baseados em nanoestruturas para o tratamento do cancro
Co-supervisor
 Química Medicinal (Master)
Universidade do Minho Departamento de Química, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2012 - 2013 Síntese de compostos relacionados com o ácido cinâmico
Co-supervisor
 Química Medicinal (Master)
Universidade do Minho Departamento de Química, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2012 - 2013 The effect of MCT1, MCT4 and CD147 inhibition on prostate cancer survival and aggressiveness
Supervisor
 Oncology (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2009 - 2013 Role of monocarboxylate transporters in pulmonary embryonic development and lung cancer
Supervisor
 Ciências da Saúde (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2011 - 2012 Role of monocarboxylate transporters in the metabolic remodeling of glioblastomas
Supervisor
 Health Sciences (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2011 - 2012 Encapsulamento de fármacos em zeolites para utilização no tratamento do carcinoma colorretal
Co-supervisor
 Técnicas de Caracterização e Análise Química (Master)
Universidade do Minho Departamento de Química, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2011 - 2012 Formas avançadas de transporte em nanoestruturas para fins terapêuticos de fármacos para o tratamento do carcinoma colorretal
Co-supervisor
 Bioquímica Aplicada (Master)
Universidade do Minho Departamento de Química, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2008 - 2012 Expressão de marcadores metabólicos e de angio-linfangiogénese no Cancro Colorectal: associação com a localização, características clínico-patológicas e impacto no prognóstico
Co-supervisor
 Medicina (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2010 - 2011 Role of monocarboxylate transporters in colorectal carcinoma
Supervisor
 Health Sciences (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2010 - 2011 Monocarboxylate transporters as potential therapeutic targets in breast cancer: inhibition studies in vitro models
Supervisor
 Molecular and Cellular Biology (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2010 - 2011 Assessment of the role of monocarboxylate transporters in angiogenesis
Supervisor
 Health Sciences (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2010 - 2011 Antimicrobial and Antitumoral Activity of Portuguese Propolis
Supervisor
 Molecular Genetics (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
2009 - 2010 Estudo do papel dos transportadores de monocarboxilatos em carcinoma colorectal
Supervisor
 Molecular Genetics (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2006 - 2010 Role of monocarboxylate transporters in solid tumours
Supervisor
 Ciências da Saúde (PhD)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2008 - 2009 Estudo do papel dos transportadores de monocarboxilatos (MCTs) no desenvolvimento embrionário
Supervisor
 Molecular Genetics (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2008 - 2009 Avaliação do efeito de quimioprevenção do chá de Salvia officinalis num modelo de indução do cancro do cólon em ratos
Co-supervisor
 Molecular Genetics (Master)
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2007 - 2008 Avaliação do efeito dos análogos da somatostatina na inibição da angiogénese
Supervisor
 Molecular Genetics (Master)
Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2012 - Current Fundamentals of Genetics, Development and Neoplasia (2012)
Workshop (Member of the Organising Committee)
 Universidade do Minho Escola de Medicina, Portugal
2011 - Current Fundamentals of Genetics, Development and Neoplasia (2011 - 2011)
Workshop (Member of the Organising Committee)
 Universidade do Minho Escola de Medicina, Portugal
2010 - Current Fundamentals of Genetics, Development and Neoplasia (2010)
Workshop (Member of the Organising Committee)
 Universidade do Minho Escola de Medicina, Portugal
2024/05/13 - 2024/05/31 Post-graduation course: Immunometabolism, School of Medicine, University of Minho (2024/05/13 - 2024/05/31)
Workshop (Member of the Organising Committee)
 Universidade do Minho, Portugal
2022/09/28 - 2022/09/30 6th Cancer World Congress “Personalized Cancer Diagnosis and Therapy” (2022/09/28 - 2022/09/30)
Conference (Member of the Organising Committee)
2022/06/29 - 2022/07/02 ISCaM2022, Targeting metabolic dynamics in cancer, Turin, Italy (2022/06/29 - 2022/07/02)
Congress (Member of the Scientific Committee)
2021/10/05 - 2021/12/14 8th ISCaM (International Society for Cancer Metabolism) Webinar series (2021/10/05 - 2021/12/14)
Conference (Member of the Organising Committee)
 Università degli Studi di Padova, Italy
2020/10/20 - 2020/11/24 ISCaM2020 - 7th Annual meeting of the International Society of Cancer Metabolism (ISCaM)– Webinar series (2020/10/20 - 2020/11/24)
Conference (Member of the Organising Committee)
2020 - 2020 Fundamentals of Genetics, Development and Neoplasia (2020 - 2020)
Workshop
 Universidade do Minho Escola de Medicina, Portugal
2019/10/17 - 2019/10/19 6th ISCaM (international Society for Cancer Metabolism) International Congress (2019/10/17 - 2019/10/19)
Meeting (President of the Organising Committee)
 Universidade do Minho, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
2019 - 2019 Fundamentals of Genetics, Development and Neoplasia (2019 - 2019)
Workshop (Member of the Organising Committee)
 Universidade do Minho Escola de Medicina, Portugal
2018 - 2018 Fundamentals of Genetics, Development and Neoplasia (2018 - 2018) Universidade do Minho Escola de Medicina, Portugal
2017 - 2017 Fundamentals of Genetics, Development and Neoplasia (2017 - 2017)
Workshop (Member of the Organising Committee)
 Universidade do Minho Escola de Medicina, Portugal
2016/04/28 - 2016/04/29 2nd ASPIC International Congress (2016/04/28 - 2016/04/29)
Congress (Co-organisor)
2016 - 2016 Pharmacological Bases of rational Therapeutics: Antibiotherapy (2016 - 2016)
Workshop (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2016 - 2016 Fundamentals of Genetics, Development and Neoplasia (2016 - 2016)
Workshop (Member of the Organising Committee)
 Universidade do Minho Escola de Medicina, Portugal
2015 - 2015 Pharmacological Bases of rational Therapeutics: Antibiotherapy (2015 - 2015)
Workshop (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2015 - 2015 Fundamentals of Genetics, Development and Neoplasia (2015 - 2015)
Workshop (Member of the Organising Committee)
 Universidade do Minho Escola de Medicina, Portugal
2014/03/27 - 2014/03/28 Meetings in Oncology, state of the art: gastric cancer (2014/03/27 - 2014/03/28)
Meeting (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2014 - 2014 Pharmacological Bases of rational Therapeutics: Antibiotherapy (2014 - 2014)
Workshop
 Universidade do Minho Escola de Medicina, Portugal
2014 - 2014 Fundamentals of Genetics, Development and Neoplasia (2014 - 2014)
Workshop (Member of the Organising Committee)
 Universidade do Minho Escola de Medicina, Portugal
2013 - 2013 Pharmacological Bases of rational Therapeutics: Antibiotherapy (2013 - 2013)
Workshop (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2013 - 2013 Fundamentals of Genetics, Development and Neoplasia (2013 - 2013)
Workshop (Member of the Organising Committee)
 Universidade do Minho Escola de Medicina, Portugal
2012/10/29 - 2012/10/29 A one day symposium with Carlos Caldas (2012/10/29 - 2012/10/29)
Symposium (Member of the Organising Committee)
2012 - 2012 Pharmacological Bases of rational Therapeutics: Antibiotherapy (2012 - 2012)
Workshop (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2011/11/05 - 2011/11/05 Meetings in Oncology, state of the art: rectal cancer (2011/11/05 - 2011/11/05)
Meeting (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2011 - 2011 Pharmacological Bases of rational Therapeutics: Antibiotherapy (2011 - 2011)
Workshop (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2010/05/03 - 2010/05/05 How to deal with radioactive material (2010/05/03 - 2010/05/03)
Workshop (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2010/04/09 - 2010/04/10 Drug, from molecule to therapeutics (2010/04/09 - 2010/04/10)
Workshop (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2008/12/05 - 2008/12/06 Pharmacological Basis of Rational Therapeutics (2008/12/05 - 2008/12/06)
Workshop (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2007/10/19 - 2007/10/20 Reunião de Outono da Associação Portuguesa de Neuro-oncologia (2007/10/19 - 2017/10/20)
Meeting (Member of the Organising Committee)
 Universidade do Minho Escola de Medicina, Portugal
2007/04/27 - 2007/04/28 Hospital Pharmacy and Therapeutics Committees (2007/04/27 - 2007/04/28)
Meeting (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal
2006/04/29 - 2006/04/29 EGFR Targeted Cancer Therapy: From Bench to Bedside (2006/04/29 - 2006/04/29)
Meeting (Co-organisor)
 Universidade do Minho Escola de Medicina, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2022/01/19 New insights in (ab)normal fetal lung development: predictive and mechanistic studies
(Thesis) Arguer
 Ana Cristina Nunes Gonçalves (PhD)
Universidade do Minho Escola de Medicina, Portugal

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2021/12/15 Studying the chemosensitizing effect of Pirfenidone in non-small cell lung cancer cell lines.
(Thesis) Main arguer
 Helena Isabel de Freitas Branco (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021/11/25 Atuação do farmacêutico clínico e redução dos erros relacionados com medicamentos durante o tratamento de doentes oncológicos no Instituto Português de Oncologia do Porto
(Thesis) Main arguer
 Joseane John Müller (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021/07/19 Biomarker discovery and metabolic characterization of prostate cancer through tissue and urine metabolomic studies
(Thesis) Main arguer
 Ana Rita Couto Machado Lima (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
2021/04/15 ROle of the MITOchondrial fission protein DRP1 as a prognosis and predictive biomarker in the treatment of differentiated thyroid cancer (ROMITO-DRP1)
(Thesis) Main arguer
 Ana Rita Marçal Dantas de Lima (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2021/03/31 Evaluation of the systemic pro-inflammatory response associated with diabetic retinopathy as a limiting factor on the efficacy of current intravitreal treatment
(Thesis) Arguer
 Pedro Nuno Ferreira Pacheco da Silva Brito (PhD)
Universidade do Minho Escola de Medicina, Portugal
2021/02/25 Intrastromal corneal ring segment implantation for keratoconus treatment: manual technique versus femtosecond laser assisted technique
(Thesis) Arguer
 Tiago Pacheco Teixeira Monteiro (PhD)
Universidade do Minho Escola de Medicina, Portugal
2020/10/21 A Multicenter Study of Singleton Placentas Biometric Parameters and Fetal Weight in Function of Gestational-Age.
(Thesis) Arguer
 Rosete Maria Amorim Novais Nogueira Cardoso (PhD)
Universidade do Minho Escola de Medicina, Portugal
2020/09/09 Seeking for new p53-activating agents: effective therapies for colorectal cancer
(Thesis) Main arguer
 Helena Isabel Nogueira Ramos Rocha (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019/12/18 Estudo metabólico dos efeitos de compostos de casca de eucalipto em células humanas de mama tumorais e não tumorais
(Thesis) Main arguer
 Ângela da Conceição Relvas Guerra (PhD)
Universidade de Aveiro Departamento de Química, Portugal
2019/12/09 Aggressive prostate cancer GWAS SNPs and its association with clinical outcome
(Thesis) Main arguer
 Ana Rita Mendes Pinto (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019/07/04 Development of Monoclonal Antibodies for Bladder Cancer Based on Glycobiomarners: Identification of Relevent Glycoantigens and Synthesis Methodologies Thereof
(Thesis) Main arguer
 Ana Rita Pereira Azevedo (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019/06/17 Intercellular relationships in the tumor microenvironment: implications for cancer pathophysiology
(Thesis) Arguer
 Ana Isabel Ferreira de Oliveira (PhD)
Universidade do Minho Escola de Medicina, Portugal
2019/04/02 CYSTEINE, A FACILITATOR OF HYPOXIA ADAPTATION AND A PROMOTER OF DRUG-RESISTANCE - A NEW ROUTE TO BETTER DIAGNOSE AND TREAT OVARIAN CANCER PATIENTS
(Thesis) Main arguer
 Ana Sofia de Almeida Costa Nunes (PhD)
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
2019/03/22 Terapia em dispositivos médicos invasivos com imagem
(Thesis) Arguer
 José Artur Oliveira Rodrigues (PhD)
Universidade do Minho Escola de Engenharia, Portugal
2018/12/17 Deciphering key roles of WNT6 in glioblastoma: mechanistic, functional, and clinical insights
(Thesis) Arguer
 Céline Saraiva Gonçalves (PhD)
Universidade do Minho Escola de Medicina, Portugal
2018/12/13 Elucidating the role of the Coxsackie and Adenovirus Receptor (CAR) in regulating AKT signaling and glucose metabolism in cancer and inflammation.
(Thesis) Main arguer
 Ana Raquel Nabais Santiago (Master)
Universidade do Minho Centro de Biologia Molecular e Ambiental, Portugal
2018/12/13 The influence of cancer cell metabolism and microenvironment on tumour progression and drug resistance
Supervisor
 Diana Maria Tavares Valente (PhD)
Universidade do Minho Escola de Medicina, Portugal
2018/12/13 Elucidating the role of the Coxsackie and Adenovirus Receptor (CAR) in regulating AKT signaling and glucose metabolism in cancer and inflammation
(Thesis) Main arguer
 Ana Raquel Nabais Santiago (Master)
Universidade do Minho Escola de Ciências, Portugal
2018/11/14 Interplay between Warburg effect and epigenetic mechanisms in kidney cancer.
(Thesis) Main arguer
 Ana Catarina Lameirinhas (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/11/14 Interplay between Warburg effect and epigenetic mechanisms in kidney cancer
(Thesis) Main arguer
 Ana Catarina Lameirinhas (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/03/08 Unraveling the molecular targets of new ruthenium-based anticancer drugs
(Thesis) Main arguer
 Ana Rita Pinto Brás (Master)
2017/12/15 Tumor metastasis under metabolic control: characterization and potential therapeutic implications
(Thesis) Main arguer
 Valery L. Payen (PhD)
Académie universitaire Louvain, Belgium
2017/12/07 GLUT-1 related microRNAs and Glycolysis in Clear Cell Renal Cell Carcinoma
(Thesis) Main arguer
 Mariana Morais (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017/11/07 Development of new epigenetic-based biomarkers for renal cell tumors with clinical application
(Thesis) Main arguer
 Ana Sílvia Luís (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2017/11/01 Targeting Anoikis-Resistant P-Cadherin-Enriched Breast Cancer Cells by in vitro Metabolic Reprograming
(Thesis) Main arguer
 Joana Pereira (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017/09/15 The spindle assembly checkpoint: new insights into its function, regulation and therapeutic implications
(Thesis) Main arguer
 Patrícia Areias da Silva (PhD)
Universidade do Algarve, Portugal
2017/07/17 Avaliação do efeito antimicrobiano de zeólitos mono e bimetálicos em microrganismos
(Thesis) Main arguer
 • Patrícia Peixoto (Master)
Universidade do Minho Departamento de Biologia, Portugal
2017/07/13 Monocarboxylate transporters (MCTs) in breast cancer aggressiveness: therapeutic targeting and regulatory mechanisms
Supervisor
 Luísa Filipa Santos (PhD)
Universidade do Minho Escola de Medicina, Portugal
2017/06/01 The impact of non-coding alterations in glioma: hints from HOTAIR and the TERT promoter
(Thesis) Arguer
 Ana Xavier Magalhães (PhD)
Universidade do Minho Escola de Medicina, Portugal
2017/04/26 Obesity and melanoma: unravelling the cellular and molecular mechanisms
(Thesis) Arguer
 Pedro Miguel Coelho (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2017/03/20 Clinical, histological, and genetic characterization of papillary renal carcinoma (PRCC): diagnostic and therapeutic implications
(Thesis) Main arguer
 Lígia Maria Almeida (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017/03/10 Advances in Canine Mammary Cancer: A Role for Inflammatory Infiltrate in Tumor Microenvironment
(Thesis) Main arguer
 Isabel Carvalho (PhD)
Universidade de Trás-os-Montes e Alto Douro, Portugal
2017/02/21 Relevance of MUC1 splice variants in pancreatic carcinogenesis
(Thesis) Main arguer
 Andreia Sofia Sousa (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2017/01/18 Functional characterization and imaging of oxidative lactate metabolism in cancer
(Thesis) Main arguer
 Vincent Van Hée (PhD)
Académie universitaire Louvain, Belgium
2016/12/19 GE11 positive exosomes as a potential RNAi delivery system in clear cell renal cell carcinoma
(Thesis) Main arguer
 Bárbara Filipa Adem (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2016/12/16 Monocarboxylate transportes in gliomas: regulation and therapeutic implications
Supervisor
 Vera Miranda Gonçalves (PhD)
Universidade do Minho Escola de Medicina, Portugal
2016/12/05 Role of Chromatin remodelers in metastization of renal cell tumors
(Thesis) Main arguer
 Maria João Ferreira (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016/11/30 Exploring the anticancer effects of multifunctional polymer-ruthenium conjugates
(Thesis) Main arguer
 Tiago Manuel Moreira (Master)
Universidade do Minho Escola de Ciências, Portugal
2016/07/25 Metabolomics analysis for renal cell carcinoma detection and biomarker discovery
(Thesis) Arguer
 Márcia Sá Monteiro (PhD)
Universidade do Porto, Portugal
2016/07/19 Targeting Nucleolin in lung cancer, towards a personalized therapy
(Thesis) Main arguer
 Ângela Fernandes (PhD)
Universidade de Coimbra, Portugal
2016/05/25 Iron and related proteins in the breast cancer microenvironment: expression patterns in epitelial and stromal inflammatory cells and association with clinicopathological markers of behavior and progression
(Thesis) Main arguer
 Oriana Alexandra Marques (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016/03/28 Estudo da expressão de marcadores metabólicos em tumores de células germinativas, com ênfase nos transportadores de monocarboxilatos
(Thesis) Main arguer
 Eduardo Caetano (Master)
Hospital de Amor, Brazil
2016/02/22 Oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements: uncovering downstream targets and therapeutic potential
(Thesis) Main arguer
 Joana Santos (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016/02/11 The role of monocarboxylate transporters in 3-bromopyruvate effect in cancer cells
(Thesis) Arguer
 João Pedro Silva (PhD)
Universidade do Minho Escola de Ciências, Portugal
2015/11/06 Hidrogéis pH responsivos como potenciais sistemas de liberação para administração de Bevacizumabe
(Thesis) Main arguer
 Natália Noronha Ferreira (Master)
Universidade Estadual Paulista Júlio de Mesquita Filho - Câmpus de Araraquara, Brazil
2015/09/29 Role of mitochondrial dynamics proteins in the mitochondrion-rich tumors
(Thesis) Main arguer
 André Manuel Ferreira da Silva (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2015/04/07 99mTc-PEI-MP and 188Re-PEI-MP for imaging and therapy of the bladder malignant tumours-an experimental study
(Thesis) Arguer
 Sara Margarida Araújo Ferreira (PhD)
Universidade do Minho Escola de Ciências, Portugal
2014 Regulation of STEAP1 gene and its clinical significance in human prostate cancer
(Thesis) Main arguer
 Inês Margarida Amaral Santos Gomes (PhD)
Universidade da Beira Interior, Portugal
2014 Role of Monocarboxylate Transporters in Prostate Carcinoma
Supervisor
 Bárbara Beatriz Pinheiro Ribeiro de Sousa (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 Factores preditivos de resposta à terapêutica intravesical com BCG
(Thesis) Main arguer
 Luís Lima (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 Factores preditivos de resposta à terapêutica intravesical com BCG
(Thesis) Main arguer
 Luís Lima (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 Role of Monocarboxylate Transporters in Prostate Carcinoma
Supervisor
 Nelma Isabel Pértega Gomes (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 Vírus herpes-g e polimorfismos dos sistemas de processamento antigénico: importância na oncogénese e no prognóstico dos linfomas de células B
(Thesis) Arguer
 Herlânder Marques (PhD)
Universidade do Minho, Portugal
2014 Impact of mutated KRAS sugnalling on autophagy regulation in colorectal carcinoma
(Thesis) Arguer
 Sara Cristina Sequeira Alves (PhD)
Universidade do Minho, Portugal
2014 The functional role of histone methylation deregulation in renal tumorigenesis
(Thesis) Main arguer
 Francisca Guilherme Carvalho Dias (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 Circulating microRNAs and renal cell carcinoma
(Thesis) Main arguer
 Márcia Filipa Vieira Coimbra (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013 Role of monocarboxylate transporters in lung development and cancer
Supervisor
 Sara Costa Granja (PhD)
Universidade do Minho Escola de Medicina, Portugal
2013 Transition from in situ to invasive breast carcinoma
(Thesis) Main arguer
 Diana Raquel Fernandes Martins (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013 Translating Biology into Clinic: new insights on prognostic and predictive biomarkers for urothelial bladder carcinoma
(Thesis) Arguer
 Julieta Alexandra Pereira Afonso (PhD)
Universidade do Minho Escola de Medicina, Portugal
2013 3-Bromopyruvate as an anticancer agent in breast cancer cell lines: exploring the role of monocarboxylate transporters
(Thesis) Main arguer
 Ana Luísa Ribeiro (Master)
Universidade do Minho Departamento de Biologia, Portugal
2013 The effect of MCT1 and MCT4 silencing on prostate cancer survival and aggressiveness
Supervisor
 Susana Patrícia Simões Sousa (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013 IDH1 and IDH2 mutations in human gliomas and correlation with metabolic players
(Thesis) Main arguer
 Telmo Filipa Araújo Catarino (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2013 Desenvolvimento de sistemas de libertação de fármacos baseados em nanoestruturas para o tratamento do cancro
Supervisor
 Ana Filipa Barbosa Machado (Master)
Universidade do Minho Departamento de Química, Portugal
2013 Monocarboxylate transporters as angiogenic mediators: role on endothelial-tumor cell crosstalk
Supervisor
 Carla Filipa Pereira Bezerra (Master)
Universidade do Minho Escola de Medicina, Portugal
2013 Characterization of the Antitumoral Activity of Portuguese Propolis
Supervisor
 Ricardo Emanuel Silva Carvalho (Master)
Universidade do Minho Escola de Medicina, Portugal
2012 Expression of colorectal cancer metabolic and angiogenic markers: association with clinicopathological characteristics and impact on prognosis
Supervisor
 Sandra de Fátima Fernandes Martins (PhD)
Universidade do Minho Escola de Medicina, Portugal
2012 microRNAs in cancer: biological effects of microRNAs in colorectal cancer
(Thesis) Arguer
 Maria Inês da Cunha Doutel de Almeida (PhD)
Universidade do Minho Escola de Medicina, Portugal
2012 Butyrate transport in the colon epithelium and its repercussion in colorectal cancer
(Thesis) Main arguer
 Pedro Filipe Fernandes Gonçalves (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2012 Encapsulamento de fármacos em zeólitos para utilização no tratamento do carcinoma colorretal
Supervisor
 Natália Sofia Brandão Vilaça (Master)
Universidade do Minho Departamento de Química, Portugal
2012 Role of monocarboxylate transportes on the metabolic remodelling of glioblastomas
Supervisor
 Vera Mónica Miranda Gonçalves (Master)
Universidade do Minho Escola de Medicina, Portugal
2011 RTKs and MAPK pathway alterations in solid tumors: dissecting prognsotic and therapeutic biomarkers
(Thesis) Arguer
 Olga Catarina Lopes Martinho (PhD)
Universidade do Minho Escola de Medicina, Portugal
2011 The role of hipoxia in the regulation of membrane transporters
(Thesis) Main arguer
 Ana Luísa Ribeiro (PhD)
Universidade do Algarve Departamento de Ciências Biomédicas e Medicina, Portugal
2011 Estudo da atividade antimicrobiana e antitumoral do própolis português
Supervisor
 Isabel Cristina Pinto Valença (Master)
Universidade do Minho Departamento de Biologia, Portugal
2011 The role of monocarboxylate transporters in angiogenesis
Supervisor
 Marta Isabel Freitas Cunha (Master)
Universidade do Minho Escola de Medicina, Portugal
2011 Monocarboxylate transporters as potential therapeutic targets in cancer: inhibition studies in solid tumor models
Supervisor
 Luísa Filipa Morais dos Santos (Master)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2011 Role of monocarboxylate transporters in colorectal cancer
Supervisor
 Ricardo Luís Agra de Amorim (Master)
Universidade do Minho Escola de Medicina, Portugal
2010 Factores de Transcrição e Epigenética no Cancro da Mama: Novos Achados sobre a Regulação do Gene CDH3/P-Caderina
(Thesis) Arguer
 André João Almeida Marques Soares de Albergaria (PhD)
Universidade do Minho Escola de Medicina, Portugal
2010 Caracterização da expressão dos transportadores de monocarboxilatos nos tumores estromais gastrointestinais
(Thesis) Main arguer
 Antônio Talvane Torres de Oliveira (PhD)
Universidade Federal de São Paulo, Brazil
2010 Role of monocarboxylate transporters in solid tumours
Supervisor
 Céline Marques Pinheiro (PhD)
Universidade do Minho Escola de Medicina, Portugal
2010 Identification and characterization of a novel epigenetic biomarker for prostate cancer: teh EFEMP1 story
(Thesis) Main arguer
 Mafalda Sofia Fernandes Almeida (Master)
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2010 Study of the role of monocarboxylate transporters in colorectal carcinoma
Supervisor
 Helena Paula Fernandes Pereira (Master)
Universidade do Minho Departamento de Biologia, Portugal
2009 Establishment and characterization of in vivo models of glial tumors
(Thesis) Main arguer
 Ashley Novais (Master)
Universidade do Minho Departamento de Biologia, Portugal
2009 The role of monocarboxylate transporters on embryonic development on two animal models: Rattus norvegicus e Gallus gallus
Supervisor
 Sara Costa Granja (Master)
Universidade do Minho Departamento de Biologia, Portugal
2009 Chemopreventive effects of Salvia officinalis tea in a rodent cólon cancer induced model
Supervisor
 Dalila Fernanda Neto Pedro (Master)
Universidade do Minho Departamento de Biologia, Portugal
2009 COX-2 polymorphisms in colorectal carcinogenesis: a strategy for individualized chemoprevention
(Thesis) Main arguer
 Ana Carina Martins Pereira (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2008 Evaluation of the antidiabetic efficacy and safety of medicinal plants of the genus Salvia
(Thesis) Main arguer
 Marisa Ferreira de Azevedo (PhD)
Universidade do Minho Departamento de Biologia, Portugal
2008 Avaliação do efeito dos análogos da somatostatina na inibição da angiogénese
Supervisor
 Ísis Alonso (Master)
Universidade do Minho Departamento de Biologia, Portugal
2006 Spatial-temporal control of the early stages of somitogenesis in the chick embryo
(Thesis) Arguer
 Sofia Machado C. A. R. M. Cristóvão (PhD)
Universidade do Minho Escola de Medicina, Portugal

Association member

Society Organization name Role
2014 - Current International Society for Cancer Metabolism (ISCaM) Member
2013/01/01 - Current ASPIC (Associação Portuguesa de Investigação em Cancro)) Member
2007/07/12 - Current European Association for Cancer Research Member
2014/06/01 - 2018/04/01 ASPIC (Sociedade Portuguesa de Investigação em Cancro) President of the Supervisory Board

Committee member

Activity description
Role 		Institution / Organization
2019/10 - 2023/07 International Society of Cancer Metabolism
Other

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2022/10/17 - 2022/11/11 Bases Moleculares do Cancro, Percursos Complementares em Medicina, School of Medicine, University of Minho (Licenciatura) Universidade do Minho, Portugal
2022/10/31 - 2022/10/31 Pharmacological therapy of cancer, Post-Graduation in Fundamentals of Medicine 1 (Pós-Graduação) Universidade do Algarve Departamento de Ciências Biomédicas e Medicina, Portugal
2022/10/03 - 2022/10/21 Post-graduation course: Fundamentals of Genetics, Development and Neoplasia, School of Medicine, University of Minho, 3rd -21th October 2022. Universidade do Minho, Portugal
2022/08/12 - 2022/08/12 “Características universais das células”, disciplina "Biologia da Célula Neoplásica, Post-graduation program Stricto Sensu Acadêmico in Oncology, Fundação Pio XII Oncology Hospital de Amor, Brazil
2022/04/29 - 2022/04/29 “Therapeutic options in cancer”, post-graduation course “Cancer therapy: from basic research to clinic”, Biology department, University of Minho, Braga (Pós-Graduação) Universidade do Minho, Portugal
2022/04/28 - 2022/04/28 “Hypoxia as a key driver of oncogenic signaling”, Scientific meetings of the Hepatic Pathology for the residents of Pathology and Gastroenterology / Hepatology of HC Universidade de São Paulo, Brazil
2022/04/27 - 2022/04/27 “Altered metabolism in cancer”. Advanced course on oncobiology 5th Ed. (Pós-Graduação) Cooperativa de Ensino Superior Politécnico e Universitário CRL, Portugal
2021/10/14 - 2021/10/14 Antineoplastic pharmacology Medicine (Licenciatura) Universidade do Algarve - Campus de Gambelas, Portugal
2021/04/21 - 2021/04/21 “Altered metabolism in cancer”. Advanced course on oncobiology 5th Ed. (Pós-Graduação) Cooperativa de Ensino Superior Politécnico e Universitário CRL, Portugal
Distinctions

Award

2024 First prize Acceleration program
Startup Braga, Portugal
2024 IACOBUS publicacións científicas (papers) 2023-2024
Agrupamento Europeu de Cooperação Territorial – Galicia-Norte de Portugal (GNP-AECT), Spain
2023 Arqus European University Alliance Award, Karion therapeutics
2022 SpinUM 2022, 1st place – best business idea, Awarded by TecMinho, Braga, Portugal.
Universidade do Minho TecMinho, Portugal
2022 1st place – best business idea and pitch, UI-CAN, Covilhã, Portugal
2022 Innovation Award by Bluepharma | University of Coimbra, Portugal
Bluepharma, Portugal
2022 Best oral presentation award, ENJIO – Encontro Nacional de Jovens Investigadores em Oncologia, Porto, Portugal.
2020 Prize for the best poster in the conference Cancer Biology: from basic to translational research
Liga Portuguesa Contra o Cancro, Portugal
2020 Best poster prize, conference Cancer Biology: from basic to translational research, Lisbon, Portugal.
Liga Portuguesa Contra o Cancro, Portugal
2019 Poster Prize 1st place
European Association For Cancer Research, United Kingdom
2019 First prize best presentation award
International Symposium on Microencapsulation, Brazil
2015 Sabbatical fellowship
Fundação para a Ciência e a Tecnologia, Portugal
2015 Prize for the best paper
Bayer Corp, United States
2014 Menção Honrosa
Fundação Ilídio Pinho, Portugal
2012 Recognition
Sociedade Portuguesa de Senologia, Portugal
2011 Best oral presentation award
Grupo Portugês Génito-Urinário, Portugal
2011 Best oral presentation award
Sociedade Portuguesa de Oncologia, Portugal
2011 First prize oral presentation
Centro Hospitalar Universitário do Porto EPE, Portugal
2010 Menção Honrosa
Grupo Portugês Génito-Urinário, Portugal
2009 Second prize for oral communication
Yes meeting, Portugal
2009 First prize poster
European Academy of ORL-HNS, Austria
2009 Second prize poster presentation
Encontros de Primavera-Oncologia, Portugal
2007 First prize oral communication
Yes meeting, Portugal
2005 First prize poster presentation
Sociedade Portuguesa de Oncologia, Portugal
1998 Post-doc fellowship
Fundação para a Ciência e a Tecnologia, Portugal
1994 PhD fellowship
Fundação para a Ciência e a Tecnologia, Portugal
1992 Annual Prize Award for the best student
Sociedade Farmacêutica Lusitana, Portugal

Title

1998 PhD
University of Hull, United Kingdom
1992 Degree in Pharmaceutical Sciences
Universidade de Coimbra Faculdade de Farmácia, Portugal